Main Menu

Publications

Publications Highlights View all by category

Types of Publications


Journal Articles

Harrington, K.J. (2019). Ultrahigh Dose-rate Radiotherapy: Next Steps for FLASH-RT. Clin cancer res, Vol.25 (1), pp. 3-5.  show abstract

Burley, T.A., Da Pieve, C., Martins, C.D., Ciobota, D.M., Allott, L., Oyen, W.J., Harrington, K.J., Smith, G. & Kramer-Marek, G. (2019). Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models. J nucl med, Vol.60 (3), pp. 353-361.  show abstract

Wilkins, A.C., Patin, E.C., Harrington, K.J. & Melcher, A.A. (2019). The immunological consequences of radiation-induced DNA damage. J pathol, Vol.247 (5), pp. 606-614.  show abstract

Mehanna, H., Robinson, M., Hartley, A., Kong, A., Foran, B., Fulton-Lieuw, T., Dalby, M., Mistry, P., Sen, M., O'Toole, L., et al. (2019). Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial. Lancet, Vol.393 (10166), pp. 51-60.  show abstract

Wilkins, A., McDonald, F., Harrington, K. & Melcher, A. (2019). Radiotherapy enhances responses of lung cancer to CTLA-4 blockade. J immunother cancer, Vol.7 (1), p. 64.  show abstract

Cohen, E.E., Soulières, D., Le Tourneau, C., Dinis, J., Licitra, L., Ahn, M.-., Soria, A., Machiels, J.-., Mach, N., Mehra, R., et al. (2019). Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study. Lancet, Vol.393 (10167), pp. 156-167.  show abstract

Dillon, M.T., Grove, L., Newbold, K.L., Shaw, H., Brown, N.F., Mendell, J., Chen, S., Beckman, R.A., Jennings, A., Ricamara, M., et al. (2019). Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study. Clin cancer res, Vol.25 (2), pp. 487-495.  show abstract

Smith, H.G., Mansfield, D., Roulstone, V., Kyula-Currie, J.N., McLaughlin, M., Patel, R.R., Bergerhoff, K.F., Paget, J.T., Dillon, M.T., Khan, A., et al. (2019). PD-1 blockade following isolated limb perfusion with vaccinia virus prevents local and distant relapse of soft-tissue sarcoma. Clin cancer res, .  show abstract

Marabelle, A., Andtbacka, R., Harrington, K., Melero, I., Leidner, R., de Baere, T., Robert, C., Ascierto, P.A., Baurain, J.-., Imperiale, M., et al. (2018). Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT). Ann oncol, Vol.29 (11), pp. 2163-2174.  show abstract

Tree, A.C., Jones, K., Hafeez, S., Sharabiani, M.T., Harrington, K.J., Lalondrelle, S., Ahmed, M. & Huddart, R.A. (2018). Dose-limiting Urinary Toxicity With Pembrolizumab Combined With Weekly Hypofractionated Radiation Therapy in Bladder Cancer. Int j radiat oncol biol phys, Vol.101 (5), pp. 1168-1171.  show abstract

Burley, T.A., Mączyńska, J., Shah, A., Szopa, W., Harrington, K.J., Boult, J.K., Mrozek-Wilczkiewicz, A., Vinci, M., Bamber, J.C., Kaspera, W., et al. (2018). Near-infrared photoimmunotherapy targeting EGFR-Shedding new light on glioblastoma treatment. Int j cancer, Vol.142 (11), pp. 2363-2374.  show abstract

Dean, J., Wong, K., Gay, H., Welsh, L., Jones, A.-., Schick, U., Oh, J.H., Apte, A., Newbold, K., Bhide, S., et al. (2018). Incorporating spatial dose metrics in machine learning-based normal tissue complication probability (NTCP) models of severe acute dysphagia resulting from head and neck radiotherapy. Clin transl radiat oncol, Vol.8, pp. 27-39.  show abstract

Gurney-Champion, O.J., McQuaid, D., Dunlop, A., Wong, K.H., Welsh, L.C., Riddell, A.M., Koh, D.-., Oelfke, U., Leach, M.O., Nutting, C.M., et al. (2018). MRI-based Assessment of 3D Intrafractional Motion of Head and Neck Cancer for Radiation Therapy. Int j radiat oncol biol phys, Vol.100 (2), pp. 306-316.  show abstract

Lee, A.W., Ng, W.T., Pan, J.J., Poh, S.S., Ahn, Y.C., AlHussain, H., Corry, J., Grau, C., Grégoire, V., Harrington, K.J., et al. (2018). International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother oncol, Vol.126 (1), pp. 25-36.  show abstract

Heatley, N., Harrington, K.J. & Thway, K. (2018). Warthin Tumor-Like Mucoepidermoid Carcinoma. Int j surg pathol, Vol.26 (1), pp. 31-33.  show abstract

Samson, A., Scott, K.J., Taggart, D., West, E.J., Wilson, E., Nuovo, G.J., Thomson, S., Corns, R., Mathew, R.K., Fuller, M.J., et al. (2018). Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. Sci transl med, Vol.10 (422).  show abstract

Yip, K., Melcher, A., Harrington, K., Illidge, T., Nobes, J., Webster, A., Smith, D., Lorigan, P., Nathan, P. & Larkin, J., et al. (2018). Pembrolizumab in Combination with Radiotherapy for Metastatic Melanoma - Introducing the PERM Trial. Clin oncol (r coll radiol), Vol.30 (4), pp. 201-203.

Rooney, K.P., Miah, A.B., Bhide, S.A., Guerrero-Urbano, M.T., Sharabiani, M.T., Newbold, K.L., Grove, L., Harrington, K.J. & Nutting, C.M. (2018). Intensity modulated radiotherapy in locally advanced thyroid cancer: Outcomes of a sequential phase I dose-escalation study. Radiother oncol, Vol.127 (1), pp. 43-48.  show abstract

Henderson, D.R., Tree, A.C., Harrington, K.J. & van As, N.J. (2018). Dosimetric Implications of Computerised Tomography-Only versus Magnetic Resonance-Fusion Contouring in Stereotactic Body Radiotherapy for Prostate Cancer. Medicines (basel), Vol.5 (2).  show abstract

Petkar, I., Bhide, S., Newbold, K., Harrington, K. & Nutting, C. (2018). Practice patterns for the radical treatment of nasopharyngeal cancer by head and neck oncologists in the United Kingdom. Br j radiol, Vol.91 (1085), p. 20170590.  show abstract

Wong, K.H., Panek, R., Dunlop, A., Mcquaid, D., Riddell, A., Welsh, L.C., Murray, I., Koh, D.-., Leach, M.O., Bhide, S.A., et al. (2018). Changes in multimodality functional imaging parameters early during chemoradiation predict treatment response in patients with locally advanced head and neck cancer. Eur j nucl med mol imaging, Vol.45 (5), pp. 759-767.  show abstract

Ferris, R.L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A.D., Licitra, L., Harrington, K.J., Kasper, S., Vokes, E.E., Even, C., et al. (2018). Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression. Oral oncol, Vol.81, pp. 45-51.  show abstract

Grønhøj, C., Jensen, D.H., Dehlendorff, C., Marklund, L., Wagner, S., Mehanna, H., Munck-Wikland, E., Ramqvist, T., Näsman, A., Wittekindt, C., et al. (2018). Development and external validation of nomograms in oropharyngeal cancer patients with known HPV-DNA status: a European Multicentre Study (OroGrams). Br j cancer, Vol.118 (12), pp. 1672-1681.  show abstract

Comins, C., Simpson, G.R., Rogers, W., Relph, K., Harrington, K., Melcher, A., Roulstone, V., Kyula, J. & Pandha, H. (2018). Synergistic antitumour effects of rapamycin and oncolytic reovirus. Cancer gene ther, Vol.25 (5-6), pp. 148-160.  show abstract

Agaimy, A., Fonseca, I., Martins, C., Thway, K., Barrette, R., Harrington, K.J., Hartmann, A., French, C.A. & Fisher, C. (2018). NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas. Am j surg pathol, Vol.42 (7), pp. 877-884.  show abstract

Dillon, M.T., Boylan, Z., Smith, D., Guevara, J., Mohammed, K., Peckitt, C., Saunders, M., Banerji, U., Clack, G., Smith, S.A., et al. (2018). PATRIOT: A phase I study to assess the tolerability, safety and biological effects of a specific ataxia telangiectasia and Rad3-related (ATR) inhibitor (AZD6738) as a single agent and in combination with palliative radiation therapy in patients with solid tumours. Clin transl radiat oncol, Vol.12, pp. 16-20.  show abstract

Gillison, M.L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A.D., Licitra, L., Harrington, K.J., Kasper, S., Vokes, E.E., Even, C., et al. (2018). CheckMate 141: 1-Year Update and Subgroup Analysis of Nivolumab as First-Line Therapy in Patients with Recurrent/Metastatic Head and Neck Cancer. Oncologist, Vol.23 (9), pp. 1079-1082.  show abstract

Henderson, D.R., Murray, J.R., Gulliford, S.L., Tree, A.C., Harrington, K.J. & Van As, N.J. (2018). An Investigation of Dosimetric Correlates of Acute Toxicity in Prostate Stereotactic Body Radiotherapy: Dose to Urinary Trigone is Associated with Acute Urinary Toxicity. Clin oncol (r coll radiol), Vol.30 (9), pp. 539-547.  show abstract

Allin, D.M., Shaikh, R., Carter, P., Thway, K., Sharabiani, M.T., Gonzales-de-Castro, D., O'Leary, B., Garcia-Murillas, I., Bhide, S., Hubank, M., et al. (2018). Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer. Eur j cancer, Vol.103, pp. 165-175.  show abstract

Nutting, C.M., Morden, J.P., Beasley, M., Bhide, S., Cook, A., De Winton, E., Emson, M., Evans, M., Fresco, L., Gollins, S., et al. (2018). Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004). Eur j cancer, Vol.103, pp. 249-258.  show abstract

Bahig, H., Yuan, Y., Mohamed, A.S., Brock, K.K., Ng, S.P., Wang, J., Ding, Y., Hutcheson, K., McCulloch, M., Balter, P.A., et al. (2018). Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin transl radiat oncol, Vol.13, pp. 19-23.  show abstract

Tykodi, S.S., Schadendorf, D., Cella, D., Reck, M., Harrington, K., Wagner, S. & Shaw, J.W. (2018). Patient-reported outcomes with nivolumab in advanced solid cancers. Cancer treat rev, Vol.70, pp. 75-87.  show abstract

Martins, C.D., Da Pieve, C., Burley, T.A., Smith, R., Ciobota, D.M., Allott, L., Harrington, K.J., Oyen, W.J., Smith, G. & Kramer-Marek, G., et al. (2018). HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET Imaging. Clin cancer res, Vol.24 (8), pp. 1853-1865.  show abstract

Khan, A.A., Paget, J.T., McLaughlin, M., Kyula, J.N., Wilkinson, M.J., Pencavel, T., Mansfield, D., Roulstone, V., Seth, R., Halle, M., et al. (2018). Genetically modified lentiviruses that preserve microvascular function protect against late radiation damage in normal tissues. Sci transl med, Vol.10 (425).  show abstract

Annels, N.E., Arif, M., Simpson, G.R., Denyer, M., Moller-Levet, C., Mansfield, D., Butler, R., Shafren, D., Au, G., Knowles, M., et al. (2018). Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus. Mol ther oncolytics, Vol.9, pp. 1-12.  show abstract

Hafsi, H., Dillon, M.T., Barker, H.E., Kyula, J.N., Schick, U., Paget, J.T., Smith, H.G., Pedersen, M., McLaughlin, M. & Harrington, K.J., et al. (2018). Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status. Front oncol, Vol.8, p. 245.  show abstract

Panek, R., Welsh, L., Baker, L.C., Schmidt, M.A., Wong, K.H., Riddell, A.M., Koh, D.-., Dunlop, A., Mcquaid, D., d'Arcy, J.A., et al. (2017). Noninvasive Imaging of Cycling Hypoxia in Head and Neck Cancer Using Intrinsic Susceptibility MRI. Clin cancer res, Vol.23 (15), pp. 4233-4241.  show abstract

Dillon, M.T., Barker, H.E., Pedersen, M., Hafsi, H., Bhide, S.A., Newbold, K.L., Nutting, C.M., McLaughlin, M. & Harrington, K.J. (2017). Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei. Mol cancer ther, Vol.16 (1), pp. 25-34.  show abstract

Sundar, R., Valeri, N., Harrington, K.J. & Yap, T.A. (2017). Combining Molecularly Targeted Agents: Is More Always Better?. Clin cancer res, Vol.23 (5), pp. 1123-1125.  show abstract

Gujral, D.M., Long, M., Roe, J.W., Harrington, K.J. & Nutting, C.M. (2017). Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer. Clin oncol (r coll radiol), Vol.29 (1), pp. 42-50.  show abstract

Ilett, E., Kottke, T., Thompson, J., Rajani, K., Zaidi, S., Evgin, L., Coffey, M., Ralph, C., Diaz, R., Pandha, H., et al. (2017). Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy. Gene ther, Vol.24 (1), pp. 21-30.  show abstract

Wong, K.H., Kuciejewska, A., Sharabiani, M.T., Ng-Cheng-Hin, B., Hoy, S., Hurley, T., Rydon, J., Grove, L., Santos, A., Ryugenji, M., et al. (2017). A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer. Radiother oncol, Vol.122 (2), pp. 207-211.  show abstract

Patel, R., Barker, H.E., Kyula, J., McLaughlin, M., Dillon, M.T., Schick, U., Hafsi, H., Thompson, A., Khoo, V., Harrington, K., et al. (2017). An orally bioavailable Chkl inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and oncology, Vol.122 (3), pp. 470-475.

Guerreiro, F., Burgos, N., Dunlop, A., Wong, K., Petkar, I., Nutting, C., Harrington, K., Bhide, S., Newbold, K., Dearnaley, D., et al. (2017). Evaluation of a multi-atlas CT synthesis approach for MRI-only radiotherapy treatment planning. Phys med, Vol.35, pp. 7-17.  show abstract

Wong, K.H., Panek, R., Bhide, S.A., Nutting, C.M., Harrington, K.J. & Newbold, K.L. (2017). The emerging potential of magnetic resonance imaging in personalizing radiotherapy for head and neck cancer: an oncologist's perspective. Br j radiol, Vol.90 (1071), p. 20160768.  show abstract

Patel, R., Barker, H.E., Kyula, J., McLaughlin, M., Dillon, M.T., Schick, U., Hafsi, H., Thompson, A., Khoo, V., Harrington, K., et al. (2017). An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiother oncol, Vol.122 (3), pp. 470-475.  show abstract

Welsh, L., Panek, R., Riddell, A., Wong, K., Leach, M.O., Tavassoli, M., Rahman, D., Schmidt, M., Hurley, T., Grove, L., et al. (2017). Blood transfusion during radical chemo-radiotherapy does not reduce tumour hypoxia in squamous cell cancer of the head and neck. Br j cancer, Vol.116 (1), pp. 28-35.  show abstract

Dean, J.A., Welsh, L.C., Wong, K.H., Aleksic, A., Dunne, E., Islam, M.R., Patel, A., Patel, P., Petkar, I., Phillips, I., et al. (2017). Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk. Clin oncol (r coll radiol), Vol.29 (4), pp. 263-273.  show abstract

Lee, J.Y., Garcia-Murillas, I., Cutts, R.J., De Castro, D.G., Grove, L., Hurley, T., Wang, F., Nutting, C., Newbold, K., Harrington, K., et al. (2017). Predicting response to radical (chemo)radiotherapy with circulating HPV DNA in locally advanced head and neck squamous carcinoma. Br j cancer, Vol.117 (6), pp. 876-883.  show abstract

Petkar, I., Bhide, S., Newbold, K., Harrington, K. & Nutting, C. (2017). Dysphagia-optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?. Clin oncol (r coll radiol), Vol.29 (7), pp. e110-e118.  show abstract

Harrington, K.J., Ferris, R.L., Blumenschein, G., Colevas, A.D., Fayette, J., Licitra, L., Kasper, S., Even, C., Vokes, E.E., Worden, F., et al. (2017). Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial. Lancet oncol, Vol.18 (8), pp. 1104-1115.  show abstract

Morgan, R., El-Tanani, M., Hunter, K.D., Harrington, K.J. & Pandha, H.S. (2017). Targeting HOX/PBX dimers in cancer. Oncotarget, Vol.8 (19), pp. 32322-32331.  show abstract

Richards, T.M., Hurley, T., Grove, L., Harrington, K.J., Carpenter, G.H., Proctor, G.B. & Nutting, C.M. (2017). The effect of parotid gland-sparing intensity-modulated radiotherapy on salivary composition, flow rate and xerostomia measures. Oral dis, Vol.23 (7), pp. 990-1000.  show abstract

Kottke, T., Evgin, L., Shim, K.G., Rommelfanger, D., Boisgerault, N., Zaidi, S., Diaz, R.M., Thompson, J., Ilett, E., Coffey, M., et al. (2017). Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence. Cancer immunol res, Vol.5 (11), pp. 1029-1045.  show abstract

Harrington, K., Hall, E., Hawkins, M., Henry, A., MacKay, R., Maughan, T., McDonald, A., Nutting, C., Oelfke, U., Sebag-Montefiore, D., et al. (2017). Introducing the Cancer Research UK Advanced Radiotherapy Technologies Network (ART-NET). Clin oncol (r coll radiol), Vol.29 (11), pp. 707-710.

Alharbi, R.A., Pandha, H.S., Simpson, G.R., Pettengell, R., Poterlowicz, K., Thompson, A., Harrington, K., El-Tanani, M. & Morgan, R. (2017). Inhibition of HOX/PBX dimer formation leads to necroptosis in acute myeloid leukemia cells. Oncotarget, Vol.8 (52), pp. 89566-89579.  show abstract

McLaughlin, M., Barker, H.E., Khan, A.A., Pedersen, M., Dillon, M., Mansfield, D.C., Patel, R., Kyula, J.N., Bhide, S.A., Newbold, K.L., et al. (2017). HSP90 inhibition sensitizes head and neck cancer to platin-based chemoradiotherapy by modulation of the DNA damage response resulting in chromosomal fragmentation. Bmc cancer, Vol.17 (1), p. 86.  show abstract

Harrington, K.J., Michielin, O., Malvehy, J., Pezzani Grüter, I., Grove, L., Frauchiger, A.L. & Dummer, R. (2017). A practical guide to the handling and administration of talimogene laherparepvec in Europe. Onco targets ther, Vol.10, pp. 3867-3880.  show abstract

Gujral, D.M., Shah, B.N., Bhattacharyya, S., Senior, R., Harrington, K.J. & Nutting, C.M. (2016). Contrast-enhanced ultrasound to assess plaque neovascularization in irradiated carotid arteries. Int j cardiol, Vol.202, pp. 3-4.

Sacco, J.J., Evans, M., Harrington, K.J., Man, S., Powell, N., Shaw, R.J. & Jones, T.M. (2016). Systemic listeriosis following vaccination with the attenuated Listeria monocytogenes therapeutic vaccine, ADXS11-001. Hum vaccin immunother, Vol.12 (4), pp. 1085-1086.

Gujral, D.M., Shah, B.N., Chahal, N.S., Bhattacharyya, S., Hooper, J., Senior, R., Harrington, K.J. & Nutting, C.M. (2016). Carotid intima-medial thickness as a marker of radiation-induced carotid atherosclerosis. Radiother oncol, Vol.118 (2), pp. 323-329.  show abstract

Rajani, K., Parrish, C., Kottke, T., Thompson, J., Zaidi, S., Ilett, L., Shim, K.G., Diaz, R.-., Pandha, H., Harrington, K., et al. (2016). Combination Therapy With Reovirus and Anti-PD-1 Blockade Controls Tumor Growth Through Innate and Adaptive Immune Responses. Mol ther, Vol.24 (1), pp. 166-174.  show abstract

Gujral, D.M., Shah, B.N., Chahal, N.S., Bhattacharyya, S., Senior, R., Harrington, K.J. & Nutting, C.M. (2016). Arterial Stiffness as a Biomarker of Radiation-Induced Carotid Atherosclerosis. Angiology, Vol.67 (3), pp. 266-271.  show abstract

Mehanna, H., Franklin, N., Compton, N., Robinson, M., Powell, N., Biswas-Baldwin, N., Paleri, V., Hartley, A., Fresco, L., Al-Booz, H., et al. (2016). Geographic variation in human papillomavirus-related oropharyngeal cancer: Data from 4 multinational randomized trials. Head neck, Vol.38 Suppl 1, pp. E1863-E1869.  show abstract

Dean, J.A., Welsh, L.C., McQuaid, D., Wong, K.H., Aleksic, A., Dunne, E., Islam, M.R., Patel, A., Patel, P., Petkar, I., et al. (2016). Assessment of fully-automated atlas-based segmentation of novel oral mucosal surface organ-at-risk. Radiother oncol, Vol.119 (1), pp. 166-171.  show abstract

Mansfield, D.C., Kyula, J.N., Rosenfelder, N., Chao-Chu, J., Kramer-Marek, G., Khan, A.A., Roulstone, V., McLaughlin, M., Melcher, A.A., Vile, R.G., et al. (2016). Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer. Gene ther, Vol.23 (4), pp. 357-368.  show abstract

Roe, J.W., Carding, P.N., Drinnan, M.J., Harrington, K.J. & Nutting, C.M. (2016). Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer. Head neck, Vol.38 Suppl 1, pp. E1436-E1444.  show abstract

Jones, T.M., De, M., Foran, B., Harrington, K. & Mortimore, S. (2016). Laryngeal cancer: United Kingdom National Multidisciplinary guidelines. J laryngol otol, Vol.130 (S2), pp. S75-S82.  show abstract

Dwivedi, R.C., St Rose, S., Chisholm, E.J., Clarke, P.M., Kerawala, C.J., Nutting, C.M., Rhys-Evans, P.H., Kazi, R. & Harrington, K.J. (2016). Acoustic parameters of speech: Lack of correlation with perceptual and questionnaire-based speech evaluation in patients with oral and oropharyngeal cancer treated with primary surgery. Head neck, Vol.38 (5), pp. 670-676.  show abstract

Wilkinson, M.J., Smith, H.G., McEntee, G., Kyula-Currie, J., Pencavel, T.D., Mansfield, D.C., Khan, A.A., Roulstone, V., Hayes, A.J. & Harrington, K.J., et al. (2016). Oncolytic vaccinia virus combined with radiotherapy induces apoptotic cell death in sarcoma cells by down-regulating the inhibitors of apoptosis. Oncotarget, Vol.7 (49), pp. 81208-81222.  show abstract

Petkar, I., Rooney, K., Roe, J.W., Patterson, J.M., Bernstein, D., Tyler, J.M., Emson, M.A., Morden, J.P., Mertens, K., Miles, E., et al. (2016). DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. Bmc cancer, Vol.16 (1), p. 770.  show abstract

Gujral, D.M., Shah, B.N., Chahal, N.S., Bhattacharyya, S., Senior, R., Harrington, K.J. & Nutting, C.M. (2016). Do traditional risk stratification models for cerebrovascular events apply in irradiated head and neck cancer patients?. Qjm, Vol.109 (6), pp. 383-389.  show abstract

Shah, B.N., Gujral, D.M., Chahal, N.S., Harrington, K.J., Nutting, C.M. & Senior, R. (2016). Plaque Neovascularization Is Increased in Human Carotid Atherosclerosis Related to Prior Neck Radiotherapy A Contrast-Enhanced Ultrasound Study. Jacc-cardiovascular imaging, Vol.9 (6), pp. 668-675.

Gujral, D.M., Cheung, W.K., Shah, B.N., Chahal, N.S., Bhattacharyya, S., Hooper, J., Senior, R., Tang, M.-., Harrington, K.J. & Nutting, C.M., et al. (2016). Contrast enhancement of carotid adventitial vasa vasorum as a biomarker of radiation-induced atherosclerosis. Radiother oncol, Vol.120 (1), pp. 63-68.  show abstract

Dean, J.A., Wong, K.H., Welsh, L.C., Jones, A.-., Schick, U., Newbold, K.L., Bhide, S.A., Harrington, K.J., Nutting, C.M. & Gulliford, S.L., et al. (2016). Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy. Radiother oncol, Vol.120 (1), pp. 21-27.  show abstract

Panek, R., Welsh, L., Dunlop, A., Wong, K.H., Riddell, A.M., Koh, D.-., Schmidt, M.A., Doran, S., Mcquaid, D., Hopkinson, G., et al. (2016). Repeatability and sensitivity of T2* measurements in patients with head and neck squamous cell carcinoma at 3T. J magn reson imaging, Vol.44 (1), pp. 72-80.  show abstract

McQuaid, D., Dunlop, A., Nill, S., Franzese, C., Nutting, C.M., Harrington, K.J., Newbold, K.L. & Bhide, S.A. (2016). Evaluation of radiotherapy techniques for radical treatment of lateralised oropharyngeal cancers : Dosimetry and NTCP. Strahlenther onkol, Vol.192 (8), pp. 516-525.  show abstract

Miah, A.B., Bhide, S.A., Del Rosario, L., Matthews, J., Nicol, R., Tanay, M.A., Gupta, S., Zaidi, S.H., Newbold, K.L., Harrington, K.J., et al. (2016). Induction Chemotherapy Followed by Chemo-intensity-modulated Radiotherapy for Locally Advanced Nasopharyngeal Cancer. Clin oncol (r coll radiol), Vol.28 (8), pp. e61-e67.  show abstract

Barker, H.E., Patel, R., McLaughlin, M., Schick, U., Zaidi, S., Nutting, C.M., Newbold, K.L., Bhide, S. & Harrington, K.J. (2016). CHK1 Inhibition Radiosensitizes Head and Neck Cancers to Paclitaxel-Based Chemoradiotherapy. Mol cancer ther, Vol.15 (9), pp. 2042-2054.  show abstract

Richards, T.M., Bhide, S.A., Miah, A.B., Del Rosario, L., Bodla, S., Thway, K., Gujral, D.M., Rooney, K.P., Schick, U., McGovern, T., et al. (2016). Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies. Clin oncol (r coll radiol), Vol.28 (9), pp. e77-e84.  show abstract

Miah, A.B., Gulliford, S.L., Morden, J., Newbold, K.L., Bhide, S.A., Zaidi, S.H., Hall, E., Harrington, K.J. & Nutting, C.M. (2016). Recovery of Salivary Function: Contralateral Parotid-sparing Intensity-modulated Radiotherapy versus Bilateral Superficial Lobe Parotid-sparing Intensity-modulated Radiotherapy. Clin oncol (r coll radiol), Vol.28 (9), pp. e69-e76.  show abstract

Ferris, R.L., Blumenschein, G., Fayette, J., Guigay, J., Colevas, A.D., Licitra, L., Harrington, K., Kasper, S., Vokes, E.E., Even, C., et al. (2016). Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N engl j med, Vol.375 (19), pp. 1856-1867.  show abstract

Sharma, R.A., Plummer, R., Stock, J.K., Greenhalgh, T.A., Ataman, O., Kelly, S., Clay, R., Adams, R.A., Baird, R.D., Billingham, L., et al. (2016). Clinical development of new drug-radiotherapy combinations. Nat rev clin oncol, Vol.13 (10), pp. 627-642.  show abstract

Harrington, K.J. & Bourhis, J. (2016). Reply to N F Saba and S J Wong. J clin oncol, Vol.34 (17), pp. 2073-2074.

Panek, R., Schmidt, M.A., Borri, M., Koh, D.-., Riddell, A., Welsh, L., Dunlop, A., Powell, C., Bhide, S.A., Nutting, C.M., et al. (2016). Time-resolved angiography with stochastic trajectories for dynamic contrast-enhanced MRI in head and neck cancer: Are pharmacokinetic parameters affected?. Med phys, Vol.43 (11), p. 6024.  show abstract

Morgan, R., Simpson, G., Gray, S., Gillett, C., Tabi, Z., Spicer, J., Harrington, K.J. & Pandha, H.S. (2016). HOX transcription factors are potential targets and markers in malignant mesothelioma. Bmc cancer, Vol.16, p. 85.  show abstract

Andtbacka, R.H., Agarwala, S.S., Ollila, D.W., Hallmeyer, S., Milhem, M., Amatruda, T., Nemunaitis, J.J., Harrington, K.J., Chen, L., Shilkrut, M., et al. (2016). Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanoma. Head neck, Vol.38 (12), pp. 1752-1758.  show abstract

Wong, K.H., Panek, R., Welsh, L., Mcquaid, D., Dunlop, A., Riddell, A., Murray, I., Du, Y., Chua, S., Koh, D.-., et al. (2016). The Predictive Value of Early Assessment After 1 Cycle of Induction Chemotherapy with 18F-FDG PET/CT and Diffusion-Weighted MRI for Response to Radical Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma. J nucl med, Vol.57 (12), pp. 1843-1850.  show abstract

Schache, A.G., Powell, N.G., Cuschieri, K.S., Robinson, M., Leary, S., Mehanna, H., Rapozo, D., Long, A., Cubie, H., Junor, E., et al. (2016). HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology. Cancer res, Vol.76 (22), pp. 6598-6606.  show abstract

Dean, J.A., Wong, K.H., Gay, H., Welsh, L.C., Jones, A.-., Schick, U., Oh, J.H., Apte, A., Newbold, K.L., Bhide, S.A., et al. (2016). Functional Data Analysis Applied to Modeling of Severe Acute Mucositis and Dysphagia Resulting From Head and Neck Radiation Therapy. Int j radiat oncol biol phys, Vol.96 (4), pp. 820-831.  show abstract

Wilkinson, M.J., Smith, H.G., Pencavel, T.D., Mansfield, D.C., Kyula-Currie, J., Khan, A.A., McEntee, G., Roulstone, V., Hayes, A.J. & Harrington, K.J., et al. (2016). Isolated limb perfusion with biochemotherapy and oncolytic virotherapy combines with radiotherapy and surgery to overcome treatment resistance in an animal model of extremity soft tissue sarcoma. Int j cancer, Vol.139 (6), pp. 1414-1422.  show abstract

McEntee, G., Kyula, J.N., Mansfield, D., Smith, H., Wilkinson, M., Gregory, C., Roulstone, V., Coffey, M. & Harrington, K.J. (2016). Enhanced cytotoxicity of reovirus and radiotherapy in melanoma cells is mediated through increased viral replication and mitochondrial apoptotic signalling. Oncotarget, Vol.7 (30), pp. 48517-48532.  show abstract

Bhide, S.A., Thway, K., Lee, J., Wong, K., Clarke, P., Newbold, K.L., Nutting, C.M. & Harrington, K.J. (2016). Delayed DNA double-strand break repair following platin-based chemotherapy predicts treatment response in head and neck squamous cell carcinoma. Br j cancer, Vol.115 (7), pp. 825-830.  show abstract

Kottke, T., Shim, K.G., Alonso-Camino, V., Zaidi, S., Maria Diaz, R., Pulido, J., Thompson, J., Rajani, K.R., Evgin, L., Ilett, E., et al. (2016). Immunogenicity of self tumor associated proteins is enhanced through protein truncation. Mol ther oncolytics, Vol.3, p. 16030.  show abstract

Harrington, K.J., Andtbacka, R.H., Collichio, F., Downey, G., Chen, L., Szabo, Z. & Kaufman, H.L. (2016). Efficacy and safety of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor in patients with stage IIIB/C and IVM1a melanoma: subanalysis of the Phase III OPTiM trial. Onco targets ther, Vol.9, pp. 7081-7093.  show abstract

Kerkmeijer, L.G., Fuller, C.D., Verkooijen, H.M., Verheij, M., Choudhury, A., Harrington, K.J., Schultz, C., Sahgal, A., Frank, S.J., Goldwein, J., et al. (2016). The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Front oncol, Vol.6, p. 215.  show abstract

Simpson, G.R., Relph, K., Harrington, K., Melcher, A. & Pandha, H. (2016). Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances. Oncolytic virother, Vol.5, pp. 1-13.  show abstract

Kaufman, H.L., Amatruda, T., Reid, T., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., Nemunaitis, J., Zloza, A., Wolf, M., et al. (2016). Systemic versus local responses in melanoma patients treated with talimogene laherparepvec from a multi-institutional phase II study. J immunother cancer, Vol.4, p. 12.  show abstract

Andtbacka, R.H., Kaufman, H.L., Collichio, F., Amatruda, T., Senzer, N., Chesney, J., Delman, K.A., Spitler, L.E., Puzanov, I., Agarwala, S.S., et al. (2015). Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma. J clin oncol, Vol.33 (25), pp. 2780-2788.  show abstract

Otter, S., Schick, U., Gulliford, S., Lal, P., Franceschini, D., Newbold, K., Nutting, C., Harrington, K. & Bhide, S. (2015). Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose Distributions. Int j radiat oncol biol phys, Vol.93 (3), pp. 507-515.  show abstract

Blanchard, M., Shim, K.G., Grams, M.P., Rajani, K., Diaz, R.M., Furutani, K.M., Thompson, J., Olivier, K.R., Park, S.S., Markovic, S.N., et al. (2015). Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Int j radiat oncol biol phys, Vol.93 (3), pp. 577-587.  show abstract

Bogaerts, J., Sydes, M.R., Keat, N., McConnell, A., Benson, A., Ho, A., Roth, A., Fortpied, C., Eng, C., Peckitt, C., et al. (2015). Clinical trial designs for rare diseases: studies developed and discussed by the International Rare Cancers Initiative. Eur j cancer, Vol.51 (3), pp. 271-281.  show abstract

Seth, R., Khan, A.A., Pencavel, T.D., Wilkinson, M.J., Kyula, J.N., Simpson, G., Pandha, H., Melcher, A., Vile, R., Harris, P.A., et al. (2015). Adenovirally delivered enzyme prodrug therapy with herpes simplex virus-thymidine kinase in composite tissue free flaps shows therapeutic efficacy in rat models of glioma. Plast reconstr surg, Vol.135 (2), pp. 475-487.  show abstract

Wilkins, A., Furness, A., Corbett, R.W., Bloomfield, A., Porta, N., Morris, S., Ali, Z., Larkin, J. & Harrington, K. (2015). The melanoma-specific graded prognostic assessment does not adequately discriminate prognosis in a modern population with brain metastases from malignant melanoma. Br j cancer, Vol.113 (9), pp. 1275-1281.  show abstract

Dean, J.A., Welsh, L.C., Gulliford, S.L., Harrington, K.J. & Nutting, C.M. (2015). A novel method for delineation of oral mucosa for radiotherapy dose-response studies. Radiother oncol, Vol.115 (1), pp. 63-66.  show abstract

Zaidi, S., Blanchard, M., Shim, K., Ilett, E., Rajani, K., Parrish, C., Boisgerault, N., Kottke, T., Thompson, J., Celis, E., et al. (2015). Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents. Mol ther, Vol.23 (5), pp. 845-856.  show abstract

Roulstone, V., Pedersen, M., Kyula, J., Mansfield, D., Khan, A.A., McEntee, G., Wilkinson, M., Karapanagiotou, E., Coffey, M., Marais, R., et al. (2015). BRAF- and MEK-Targeted Small Molecule Inhibitors Exert Enhanced Antimelanoma Effects in Combination With Oncolytic Reovirus Through ER Stress. Mol ther, Vol.23 (5), pp. 931-942.  show abstract

Miah, A.B., Schick, U., Bhide, S.A., Guerrero-Urbano, M.-., Clark, C.H., Bidmead, A.M., Bodla, S., Del Rosario, L., Thway, K., Wilson, P., et al. (2015). A phase II trial of induction chemotherapy and chemo-IMRT for head and neck squamous cell cancers at risk of bilateral nodal spread: the application of a bilateral superficial lobe parotid-sparing IMRT technique and treatment outcomes. Br j cancer, Vol.112 (1), pp. 32-38.  show abstract

Cheung, W.K., Gujral, D.M., Shah, B.N., Chahal, N.S., Bhattacharyya, S., Cosgrove, D.O., Eckersley, R.J., Harrington, K.J., Senior, R., Nutting, C.M., et al. (2015). Attenuation Correction and Normalisation for Quantification of Contrast Enhancement in Ultrasound Images of Carotid Arteries. Ultrasound med biol, Vol.41 (7), pp. 1876-1883.  show abstract

Barker, H.E., Paget, J.T., Khan, A.A. & Harrington, K.J. (2015). The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat rev cancer, Vol.15 (7), pp. 409-425.  show abstract

Dillon, M.T. & Harrington, K.J. (2015). Human Papillomavirus-Negative Pharyngeal Cancer. J clin oncol, Vol.33 (29), pp. 3251-3261.  show abstract

Harrington, K., Temam, S., Mehanna, H., D'Cruz, A., Jain, M., D'Onofrio, I., Manikhas, G., Horvath, Z., Sun, Y., Dietzsch, S., et al. (2015). Postoperative Adjuvant Lapatinib and Concurrent Chemoradiotherapy Followed by Maintenance Lapatinib Monotherapy in High-Risk Patients With Resected Squamous Cell Carcinoma of the Head and Neck: A Phase III, Randomized, Double-Blind, Placebo-Controlled Study. J clin oncol, Vol.33 (35), pp. 4202-4209.  show abstract

Schick, U., Kyula, J., Barker, H., Patel, R., Zaidi, S., Gregory, C., Hafsi, H., Roulstone, V., Deutsch, E., McLaughlin, M., et al. (2015). Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiother oncol, Vol.117 (2), pp. 364-375.  show abstract

Dunlop, A., McQuaid, D., Nill, S., Murray, J., Poludniowski, G., Hansen, V.N., Bhide, S., Nutting, C., Harrington, K., Newbold, K., et al. (2015). Comparison of CT number calibration techniques for CBCT-based dose calculation. Strahlenther onkol, Vol.191 (12), pp. 970-978.  show abstract

Pencavel, T.D., Wilkinson, M.J., Mansfield, D.C., Khan, A.A., Seth, R., Karapanagiotou, E.M., Roulstone, V., Aguilar, R.J., Chen, N.G., Szalay, A.A., et al. (2015). Isolated limb perfusion with melphalan, tumour necrosis factor-alpha and oncolytic vaccinia virus improves tumour targeting and prolongs survival in a rat model of advanced extremity sarcoma. Int j cancer, Vol.136 (4), pp. 965-976.  show abstract

Roulstone, V., Khan, K., Pandha, H.S., Rudman, S., Coffey, M., Gill, G.M., Melcher, A.A., Vile, R., Harrington, K.J., de Bono, J., et al. (2015). Phase I trial of cyclophosphamide as an immune modulator for optimizing oncolytic reovirus delivery to solid tumors. Clin cancer res, Vol.21 (6), pp. 1305-1312.  show abstract

Welsh, L., Panek, R., McQuaid, D., Dunlop, A., Schmidt, M., Riddell, A., Koh, D.-., Doran, S., Murray, I., Du, Y., et al. (2015). Prospective, longitudinal, multi-modal functional imaging for radical chemo-IMRT treatment of locally advanced head and neck cancer: the INSIGHT study. Radiat oncol, Vol.10, p. 112.  show abstract

Harrington, K.J., Puzanov, I., Hecht, J.R., Hodi, F.S., Szabo, Z., Murugappan, S. & Kaufman, H.L. (2015). Clinical development of talimogene laherparepvec (T-VEC): a modified herpes simplex virus type-1-derived oncolytic immunotherapy. Expert rev anticancer ther, Vol.15 (12), pp. 1389-1403.  show abstract

Appleton, E.S., Turnbull, S., Ralph, C., West, E., Scott, K., Harrington, K., Pandha, H. & Melcher, A. (2015). Talimogene laherparepvec in the treatment of melanoma. Expert opin biol ther, Vol.15 (10), pp. 1517-1530.  show abstract

Borri, M., Schmidt, M.A., Powell, C., Koh, D.-., Riddell, A.M., Partridge, M., Bhide, S.A., Nutting, C.M., Harrington, K.J., Newbold, K.L., et al. (2015). Characterizing Heterogeneity within Head and Neck Lesions Using Cluster Analysis of Multi-Parametric MRI Data. Plos one, Vol.10 (9), p. e0138545.  show abstract

Dunlop, A., Welsh, L., McQuaid, D., Dean, J., Gulliford, S., Hansen, V., Bhide, S., Nutting, C., Harrington, K. & Newbold, K., et al. (2015). Brain-sparing methods for IMRT of head and neck cancer. Plos one, Vol.10 (3), p. e0120141.  show abstract

Nemunaitis, J.J., Andtbacka, R.H., Ross, M., Amatruda, T., Chesney, J., Collichio, F.A., Harrington, K.J., Steven, N.M., Fourie, S., Dreosti, L., et al. (2014). 1102PRESULTS OF THE EXTENSION TRIAL OF OPTIM, A MULTICENTER, RANDOMIZED PHASE 3 TRIAL OF TALIMOGENE LAHERPAREPVEC (T-VEC) VS GM-CSF FOR UNRESECTED STAGE IIIB-IV MELANOMA. Ann oncol, Vol.25 (suppl_4), p. iv382.

Gujral, D.M., Chahal, N., Senior, R., Harrington, K.J. & Nutting, C.M. (2014). Radiation-induced carotid artery atherosclerosis. Radiother oncol, Vol.110 (1), pp. 31-38.  show abstract

Jennings, V.A., Ilett, E.J., Scott, K.J., West, E.J., Vile, R., Pandha, H., Harrington, K., Young, A., Hall, G.D., Coffey, M., et al. (2014). Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites. International journal of cancer, Vol.134 (5), pp. 1091-1101.

Taylor, G.S., Jia, H., Harrington, K., Lee, L.W., Turner, J., Ladell, K., Price, D.A., Tanday, M., Matthews, J., Roberts, C., et al. (2014). A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer. Clin cancer res, Vol.20 (19), pp. 5009-5022.  show abstract

Gujral, D.M., Shah, B.N., Chahal, N.S., Senior, R., Harrington, K.J. & Nutting, C.M. (2014). Clinical features of radiation-induced carotid atherosclerosis. Clin oncol (r coll radiol), Vol.26 (2), pp. 94-102.  show abstract

Gujral, D.M., Piercy, D., Morden, J.P., Emson, M., Hall, E., Miah, A.B., Bhide, S.A., Newbold, K.L., Harrington, K.J. & Nutting, C.M., et al. (2014). Current attitudes of head and neck oncologists in the United Kingdom to induction chemotherapy for locally advanced head and neck cancer: a survey of centres participating in a national randomised controlled trial. Oral oncol, Vol.50 (2), pp. 141-146.  show abstract

Powell, C., Schick, U., Morden, J.P., Gulliford, S.L., Miah, A.B., Bhide, S., Newbold, K., Harrington, K.J. & Nutting, C.M. (2014). Fatigue during chemoradiotherapy for nasopharyngeal cancer and its relationship to radiation dose distribution in the brain. Radiother oncol, Vol.110 (3), pp. 416-421.  show abstract

Sarris, E.G., Harrington, K.J., Saif, M.W. & Syrigos, K.N. (2014). Multimodal treatment strategies for elderly patients with head and neck cancer. Cancer treat rev, Vol.40 (3), pp. 465-475.  show abstract

Morgan, R., Boxall, A., Harrington, K.J., Simpson, G.R., Michael, A. & Pandha, H.S. (2014). Targeting HOX transcription factors in prostate cancer. Bmc urology, Vol.14.

Dillon, M.T., Good, J.S. & Harrington, K.J. (2014). Selective targeting of the G2/M cell cycle checkpoint to improve the therapeutic index of radiotherapy. Clin oncol (r coll radiol), Vol.26 (5), pp. 257-265.  show abstract

Dunlop, A., Welsh, L., Nutting, C., Harrington, K., Bhide, S. & Newbold, K. (2014). SU-E-T-198: Hippocampal-Sparing Radiotherapy (HSRT) for Patients with Head and Neck Cancer (HNC) Using Intensity-Modulated Radiation Therapy (IMRT). Med phys, Vol.41 (6), p. 268.  show abstract

Dean, J., Welsh, L., Gulliford, S., Harrington, K. & Nutting, C. (2014). SU-D-16A-02: A Novel Methodology for Accurate, Semi-Automated Delineation of Oral Mucosa for Radiation Therapy Dose-Response Studies. Med phys, Vol.41 (6), p. 108.  show abstract

Lynch, J., Lal, P., Schick, U., Nutting, C.M., Newbold, K., Harrington, K. & Bhide, S. (2014). Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. Oral oncol, Vol.50 (9), pp. 901-906.  show abstract

Ilett, E., Kottke, T., Donnelly, O., Thompson, J., Willmon, C., Diaz, R., Zaidi, S., Coffey, M., Selby, P., Harrington, K., et al. (2014). Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus. Mol ther, Vol.22 (10), pp. 1851-1863.  show abstract

Irune, E., Dwivedi, R.C., Nutting, C.M. & Harrington, K.J. (2014). Treatment-related dysgeusia in head and neck cancer patients. Cancer treat rev, Vol.40 (9), pp. 1106-1117.  show abstract

Morgan, R., Gray, S., Gillett, C., Tabi, Z., Launchbury, F., Spicer, J., Harrington, K. & Pandha, H.S. (2014). HOX TRANSCRIPTION FACTORS ARE POTENTIAL TARGETS AND MARKERS IN MALIGNANT MESOTHELIOMA. Anticancer research, Vol.34 (10), pp. 6069-6071.

Alonso-Camino, V., Rajani, K., Kottke, T., Rommelfanger-Konkol, D., Zaidi, S., Thompson, J., Pulido, J., Ilett, E., Donnelly, O., Selby, P., et al. (2014). The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site. Mol ther, Vol.22 (11), pp. 1936-1948.  show abstract

Gujral, D.M., Miah, A.B., Bodla, S., Richards, T.M., Welsh, L., Schick, U., Powell, C.J., Clark, C.H., Bidmead, M.A., Grove, L., et al. (2014). Final long-term results of a phase I/II study of dose-escalated intensity-modulated radiotherapy for locally advanced laryngo-hypopharyngeal cancers. Oral oncol, Vol.50 (11), pp. 1089-1097.  show abstract

Alonso-Camino, V., Rajani, K., Kottke, T., Rommelfanger-Konkol, D., Zaidi, S., Thompson, J., Pulido, J., Ilett, E., Donnelly, O., Selby, P., et al. (2014). The Profile of Tumor Antigens Which Can be Targeted by Immunotherapy Depends Upon the Tumor's Anatomical Site. Molecular therapy, Vol.22 (11), pp. 1936-1948.

Welsh, L.C., Dunlop, A.W., McGovern, T., McQuaid, D., Dean, J.A., Gulliford, S.L., Bhide, S.A., Harrington, K.J., Nutting, C.M. & Newbold, K.L., et al. (2014). Neurocognitive function after (chemo)-radiotherapy for head and neck cancer. Clin oncol (r coll radiol), Vol.26 (12), pp. 765-775.  show abstract

Roe, J.W., Drinnan, M.J., Carding, P.N., Harrington, K.J. & Nutting, C.M. (2014). Patient-reported outcomes following parotid-sparing intensity-modulated radiotherapy for head and neck cancer How important is dysphagia?. Oral oncol, Vol.50 (12), pp. 1182-1187.  show abstract

Kyula, J.N., Khan, A.A., Mansfield, D., Karapanagiotou, E.M., McLaughlin, M., Roulstone, V., Zaidi, S., Pencavel, T., Touchefeu, Y., Seth, R., et al. (2014). Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling. Oncogene, Vol.33 (13), pp. 1700-1712.  show abstract

Burtness, B., Bourhis, J.P., Vermorken, J.B., Harrington, K.J. & Cohen, E.E. (2014). Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized controlled trial. Trials, Vol.15.

Bradley, S., Jakes, A.D., Harrington, K., Pandha, H., Melcher, A. & Errington-Mais, F. (2014). Applications of coxsackievirus A21 in oncology. Oncolytic virother, Vol.3, pp. 47-55.  show abstract

Powell, C., Schmidt, M., Borri, M., Koh, D.-., Partridge, M., Riddell, A., Cook, G., Bhide, S.A., Nutting, C.M., Harrington, K.J., et al. (2013). Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer. Radiother oncol, Vol.106 (1), pp. 112-117.  show abstract

Donnelly, O.G., Errington-Mais, F., Steele, L., Hadac, E., Jennings, V., Scott, K., Peach, H., Phillips, R.M., Bond, J., Pandha, H., et al. (2013). Measles virus causes immunogenic cell death in human melanoma. Gene therapy, Vol.20 (1), pp. 7-15.

Mansfield, D., Pencavel, T., Kyula, J.N., Zaidi, S., Roulstone, V., Thway, K., Karapanagiotou, L., Khan, A.A., McLaughlin, M., Touchefeu, Y., et al. (2013). Oncolytic Vaccinia virus and radiotherapy in head and neck cancer. Oral oncology, Vol.49 (2), pp. 108-118.

Miah, A.B., Gulliford, S.L., Bhide, S.A., Zaidi, S.H., Newbold, K.L., Harrington, K.J. & Nutting, C.M. (2013). The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT. Radiother oncol, Vol.106 (3), pp. 346-351.  show abstract

Miah, A.B., Gulliford, S.L., Clark, C.H., Bhide, S.A., Zaidi, S.H., Newbold, K.L., Harrington, K.J. & Nutting, C.M. (2013). Dose-response analysis of parotid gland function: what is the best measure of xerostomia?. Radiother oncol, Vol.106 (3), pp. 341-345.  show abstract

Harrington, K., Berrier, A., Robinson, M., Remenar, E., Housset, M., de Mendoza, F.H., Fayette, J., Mehanna, H., El-Hariry, I., Compton, N., et al. (2013). Randomised Phase II study of oral lapatinib combined with chemoradiotherapy in patients with advanced squamous cell carcinoma of the head and neck: rationale for future randomised trials in human papilloma virus-negative disease. Eur j cancer, Vol.49 (7), pp. 1609-1618.  show abstract

Franzese, C., Gujral, D.M., Good, J., Thway, K. & Harrington, K.J. (2013). Radical radiotherapy for radiation-induced malignancy in the context of Hereditary retinoblastoma. Clin oncol (r coll radiol), Vol.25 (5), pp. 330-331.

Welsh, L., Powell, C., Pratt, B., Harrington, K., Nutting, C., Harmer, C. & Newbold, K. (2013). Long-term outcomes following low-dose radioiodide ablation for differentiated thyroid cancer. J clin endocrinol metab, Vol.98 (5), pp. 1819-1825.  show abstract

Roulstone, V., Twigger, K., Zaidi, S., Pencavel, T., Kyula, J.N., White, C., McLaughlin, M., Seth, R., Karapanagiotou, E.M., Mansfield, D., et al. (2013). Synergistic cytotoxicity of oncolytic reovirus in combination with cisplatin-paclitaxel doublet chemotherapy. Gene therapy, Vol.20 (5), pp. 521-528.

Giannopoulou, A., Gkiozos, I., Harrington, K.J. & Syrigos, K.N. (2013). Thymoma and radiation therapy: a systematic review of medical treatment. Expert review of anticancer therapy, Vol.13 (6), pp. 759-766.

Wilkins, A.C., Rosenfelder, N., Schick, U., Gupta, S., Thway, K., Nutting, C.M., Harrington, K.J., Newbold, K. & Bhide, S.A. (2013). Equivalence of cisplatin and carboplatin-based chemoradiation for locally advanced squamous cell carcinoma of the head and neck: a matched-pair analysis. Oral oncol, Vol.49 (6), pp. 615-619.  show abstract

Calvo, F., Ege, N., Grande-Garcia, A., Hooper, S., Jenkins, R.P., Chaudhry, S.I., Harrington, K., Williamson, P., Moeendarbary, E., Charras, G., et al. (2013). Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancer-associated fibroblasts. Nature cell biology, Vol.15 (6), pp. 637-+.

Touchefeu, Y., Khan, A.A., Borst, G., Zaidi, S.H., McLaughlin, M., Roulstone, V., Mansfield, D., Kyula, J., Pencavel, T., Karapanagiotou, E.M., et al. (2013). Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. Radiotherapy and oncology, Vol.108 (1), pp. 24-31.

Chaudhry, S.I., Hooper, S., Nye, E., Williamson, P., Harrington, K. & Sahai, E. (2013). Autocrine IL-1 beta-TRAF6 signalling promotes squamous cell carcinoma invasion through paracrine INF alpha, signalling to carcinoma-associated fibroblasts. Oncogene, Vol.32 (6), pp. 747-758.

Box, C., Mendiola, M., Gowan, S., Box, G.M., Valenti, M., Brandon, A.D., Al-Lazikani, B., Rogers, S.J., Wilkins, A., Harrington, K.J., et al. (2013). A novel serum protein signature associated with resistance to epidermal growth factor receptor tyrosine kinase inhibitors in head and neck squamous cell carcinoma. Eur j cancer, Vol.49 (11), pp. 2512-2521.  show abstract

Perlikos, F., Harrington, K.J. & Syrigos, K.N. (2013). Key molecular mechanisms in lung cancer invasion and metastasis: A comprehensive review. Critical reviews in oncology hematology, Vol.87 (1), pp. 1-11.

Donnelly, O., Harrington, K., Melcher, A. & Pandha, H. (2013). Live viruses to treat cancer. Journal of the royal society of medicine, Vol.106 (8), pp. 310-314.

Boisgerault, N., Kottke, T., Pulido, J., Thompson, J., Diaz, R.M., Rommelfanger-Konkol, D., Embry, A., Saenz, D., Poeschla, E., Pandha, H., et al. (2013). Functional Cloning of Recurrence-specific Antigens Identifies Molecular Targets to Treat Tumor Relapse. Molecular therapy, Vol.21 (8), pp. 1507-1516.

Kyula, J.N., Khan, A.A., Wilkinson, M.J., Mansfield, D. & Harrington, K.J. (2013). Radiation lays down covering fire for viral shock troops. Oncotarget, Vol.4 (9), pp. 1329-1330.

Pencavel, T., Seth, R., Khan, A., Wilkinson, M., Hayes, A. & Harrington, K. (2013). Isolated limb perfusion with melphalan, tnfa and oncolytic vaccinia virus delays tumour growth and prolongs survival in a rat model of locally-advanced extremity sarcoma. Int j surg, Vol.11 (8), p. 590.

Good, J.S. & Harrington, K.J. (2013). The hallmarks of cancer and the radiation oncologist: updating the 5Rs of radiobiology. Clin oncol (r coll radiol), Vol.25 (10), pp. 569-577.  show abstract

Kottke, T., Boisgerault, N., Diaz, R.M., Donnelly, O., Rommelfanger-Konkol, D., Pulido, J., Thompson, J., Mukhopadhyay, D., Kaspar, R., Coffey, M., et al. (2013). Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence. Nature medicine, Vol.19 (12), pp. 1625-1631.

Borst, G.R., McLaughlin, M., Kyula, J.N., Neijenhuis, S., Khan, A., Good, J., Zaidi, S., Powell, N.G., Meier, P., Collins, I., et al. (2013). Targeted Radiosensitization by the Chk1 Inhibitor SAR-020106. International journal of radiation oncology biology physics, Vol.85 (4), pp. 1110-1118.

Harrington, K.J. (2013). Oncolytic Virotherapy Needs Trials, Not Access Programs. Clinical cancer research, Vol.19 (10), pp. 2595-2597.

Adair, R.A., Scott, K.J., Fraser, S., Errington-Mais, F., Pandha, H., Coffey, M., Selby, P., Cook, G.P., Vile, R., Harrington, K.J., et al. (2013). Cytotoxic and immune-mediated killing of human colorectal cancer by reovirus-loaded blood and liver mononuclear cells. International journal of cancer, Vol.132 (10), pp. 2327-2338.

Harrington, K.J. (2013). Oncolytic viruses: methods and protocols. Br j cancer, Vol.108 (3), p. 735.

Karapanagiotou, E.M., Roulstone, V., Twigger, K., Ball, M., Tanay, M., Nutting, C., Newbold, K., Gore, M.E., Larkin, J., Syrigos, K.N., et al. (2012). Phase I/II trial of carboplatin and paclitaxel chemotherapy in combination with intravenous oncolytic reovirus in patients with advanced malignancies. Clin cancer res, Vol.18 (7), pp. 2080-2089.  show abstract

Bhide, S.A., Ahmed, M., Newbold, K., Harrington, K.J. & Nutting, C.M. (2012). The role of intensity modulated radiotherapy in advanced oral cavity carcinoma. J cancer res ther, Vol.8 Suppl 1, pp. S67-S71.  show abstract

Schick, U., Gujral, D.M., Richards, T.M., Harrington, K.J. & Nutting, C.M. (2012). Zalutumumab in head and neck cancer. Expert opin biol ther, Vol.12 (1), pp. 119-125.  show abstract

Dwivedi, R.C., Rose, S.S., Chisholm, E.J., Kerawala, C.J., Clarke, P.M., Nutting, C.M., Rhys-Evans, P.H., Harrington, K.J. & Kazi, R. (2012). Development and validation of first-ever speech-specific perceptual speech evaluation tool for patients with head and neck cancer: the London speech evaluation (LSE) scale. Head neck, Vol.34 (1), pp. 94-103.  show abstract

Miah, A.B., Bhide, S.A., Guerrero-Urbano, M.T., Clark, C., Bidmead, A.M., St Rose, S., Barbachano, Y., A'hern, R., Tanay, M., Hickey, J., et al. (2012). Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers. Int j radiat oncol biol phys, Vol.82 (2), pp. 539-547.  show abstract

Dwivedi, R.C., St Rose, S., Chisholm, E.J., Youssefi, P., Hassan, M.S., Khan, A.S., Elmiyeh, B., Kerawala, C.J., Clarke, P.M., Nutting, C.M., et al. (2012). Evaluation of factors affecting post-treatment quality of life in oral and oropharyngeal cancer patients primarily treated with curative surgery: an exploratory study. Eur arch otorhinolaryngol, Vol.269 (2), pp. 591-599.  show abstract

Pulido, J., Kottke, T., Thompson, J., Galivo, F., Wongthida, P., Diaz, R.M., Rommelfanger, D., Ilett, E., Pease, L., Pandha, H., et al. (2012). Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma. Nature biotechnology, Vol.30 (4), pp. 336-343.

Touchefeu, Y., Schick, U. & Harrington, K.J. (2012). [Measles virus: a future therapeutic agent in oncology?]. Med sci (paris), Vol.28 (4), pp. 388-394.  show abstract

Buettner, F., Miah, A.B., Gulliford, S.L., Hall, E., Harrington, K.J., Webb, S., Partridge, M. & Nutting, C.M. (2012). Novel approaches to improve the therapeutic index of head and neck radiotherapy: an analysis of data from the PARSPORT randomised phase III trial. Radiother oncol, Vol.103 (1), pp. 82-87.  show abstract

Bhide, S.A., Gulliford, S., Schick, U., Miah, A., Zaidi, S., Newbold, K., Nutting, C.M. & Harrington, K.J. (2012). Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer. Radiother oncol, Vol.103 (1), pp. 88-91.  show abstract

Roe, J.W., Carding, P.N., Rhys-Evans, P.H., Newbold, K.L., Harrington, K.J. & Nutting, C.M. (2012). Assessment and management of dysphagia in patients with head and neck cancer who receive radiotherapy in the United Kingdom - a web-based survey. Oral oncol, Vol.48 (4), pp. 343-348.  show abstract

Dwivedi, R.C., Chisholm, E.J., Khan, A.S., Harris, N.J., Bhide, S.A., St Rose, S., Kerawala, C.J., Clarke, P.M., Nutting, C.M., Rhys-Evans, P.H., et al. (2012). An exploratory study of the influence of clinico-demographic variables on swallowing and swallowing-related quality of life in a cohort of oral and oropharyngeal cancer patients treated with primary surgery. Eur arch otorhinolaryngol, Vol.269 (4), pp. 1233-1239.  show abstract

Bhide, S.A., Newbold, K.L., Harrington, K.J. & Nutting, C.M. (2012). Clinical evaluation of intensity-modulated radiotherapy for head and neck cancers. Br j radiol, Vol.85 (1013), pp. 487-494.  show abstract

Dwivedi, R.C., St Rose, S., Chisholm, E.J., Bisase, B., Amen, F., Nutting, C.M., Clarke, P.M., Kerawala, C.J., Rhys-Evans, P.H., Harrington, K.J., et al. (2012). Evaluation of speech outcomes using English version of the Speech Handicap Index in a cohort of head and neck cancer patients. Oral oncol, Vol.48 (6), pp. 547-553.  show abstract

Donnelly, O.G., Errington-Mais, F., Prestwich, R., Harrington, K., Pandha, H., Vile, R. & Melcher, A.A. (2012). Recent Clinical Experience with Oncolytic Viruses. Current pharmaceutical biotechnology, Vol.13 (9), pp. 1834-1841.

Murray, J.R., Williams, G.R., Harrington, K.J., Newbold, K. & Nutting, C.M. (2012). Rising thyroglobulin tumour marker during pregnancy in a thyroid cancer patient: no cause for alarm?. Clin endocrinol (oxf), Vol.77 (1), pp. 155-157.

Gulliford, S.L., Miah, A.B., Brennan, S., McQuaid, D., Clark, C.H., Partridge, M., Harrington, K.J., Morden, J.P., Hall, E. & Nutting, C.M., et al. (2012). Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother oncol, Vol.104 (2), pp. 205-212.  show abstract

Donnelly, O., Vile, R., Pandha, H., Harrington, K. & Melcher, A. (2012). The Hitchhiker's Guide to Virotherapy. Oncotarget, Vol.3 (8), pp. 735-736.

Khattak, M., Gore, M., Larkin, J., Strauss, D., Thomas, M., Hayes, A. & Harrington, K. (2012). Adjuvant nodal irradiation in melanoma. Lancet oncol, Vol.13 (8), pp. e326-e327.

Seth, R., Khan, A.A., Pencavel, T., Harrington, K.J. & Harris, P.A. (2012). Targeted gene delivery by free-tissue transfer in oncoplastic reconstruction. Lancet oncol, Vol.13 (9), pp. e392-e402.  show abstract

Nuovo, G.J., Garofalo, M., Valeri, N., Roulstone, V., Volinia, S., Cohn, D.E., Phelps, M., Harrington, K.J., Vile, R., Melcher, A., et al. (2012). Reovirus-associated reduction of microRNA-let-7d is related to the increased apoptotic death of cancer cells in clinical samples. Mod pathol, Vol.25 (10), pp. 1333-1344.  show abstract

Galanis, E., Markovic, S.N., Suman, V.J., Nuovo, G.J., Vile, R.G., Kottke, T.J., Nevala, W.K., Thompson, M.A., Lewis, J.E., Rumilla, K.M., et al. (2012). Phase II Trial of Intravenous Administration of Reolysin (R) (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma. Molecular therapy, Vol.20 (10), pp. 1998-2003.

Morgan, R., Boxall, A., Harrington, K.J., Simpson, G.R., Gillett, C., Michael, A. & Pandha, H.S. (2012). Targeting the HOX/PBX dimer in breast cancer. Breast cancer research and treatment, Vol.136 (2), pp. 389-398.

Kyula, J.N., Roulstone, V., Karapanagiotou, E.M., Melcher, A.A. & Harrington, K.J. (2012). Oncolytic reovirus type 3 (Dearing) as a novel therapy in head and neck cancer. Expert opinion on biological therapy, Vol.12 (12), pp. 1669-1678.

Dwivedi, R.C., St Rose, S., Chisholm, E.J., Georgalas, C., Bisase, B., Amen, F., Kerawala, C.J., Clarke, P.M., Nutting, C.M., Rhys-Evans, P.H., et al. (2012). Evaluation of swallowing by Sydney Swallow Questionnaire (SSQ) in oral and oropharyngeal cancer patients treated with primary surgery. Dysphagia, Vol.27 (4), pp. 491-497.  show abstract

Adair, R.A., Roulstone, V., Scott, K.J., Morgan, R., Nuovo, G.J., Fuller, M., Beirne, D., West, E.J., Jennings, V.A., Rose, A., et al. (2012). Cell Carriage, Delivery, and Selective Replication of an Oncolytic Virus in Tumor in Patients. Science translational medicine, Vol.4 (138).

Twigger, K., Roulstone, V., Kyula, J., Karapanagiotou, E.M., Syrigos, K.N., Morgan, R., White, C., Bhide, S., Nuovo, G., Coffey, M., et al. (2012). Reovirus exerts potent oncolytic effects in head and neck cancer cell lines that are independent of signalling in the EGFR pathway. Bmc cancer, Vol.12, p. 368.  show abstract

Simpson, G.R., Horvath, A., Annels, N.E., Pencavel, T., Metcalf, S., Seth, R., Peschard, P., Price, T., Coffin, R.S., Mostafid, H., et al. (2012). Combination of a fusogenic glycoprotein, pro-drug activation and oncolytic HSV as an intravesical therapy for superficial bladder cancer. British journal of cancer, Vol.106 (3), pp. 496-507.

Zaidi, S., McLaughlin, M., Bhide, S.A., Eccles, S.A., Workman, P., Nutting, C.M., Huddart, R.A. & Harrington, K.J. (2012). The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage. Plos one, Vol.7 (4), p. e35436.  show abstract

Touchefeu, Y., Franken, P. & Harrington, K.J. (2012). Radiovirotherapy: principles and prospects in oncology. Curr pharm des, Vol.18 (22), pp. 3313-3320.  show abstract

Newbold, K.L., Bhide, S., Convery, H., Harrington, K.J. & Nutting, C.M. (2012). Prospective intra-patient evaluation of a shoulder retraction device for radiotherapy in head and neck cancer. Med dosim, Vol.37 (3), pp. 293-295.  show abstract

Ilett, E.J., Barcena, M., Errington-Mais, F., Griffin, S., Harrington, K.J., Pandha, H.S., Coffey, M., Selby, P.J., Limpens, R.W., Mommaas, M., et al. (2011). Internalization of Oncolytic Reovirus by Human Dendritic Cell Carriers Protects the Virus from Neutralization. Clin cancer res, Vol.17 (9), pp. 2767-2776.  show abstract

Willmon, C., Diaz, R.M., Wongthida, P., Galivo, F., Kottke, T., Thompson, J., Albelda, S., Harrington, K., Melcher, A. & Vile, R., et al. (2011). Vesicular Stomatitis Virus-induced Immune Suppressor Cells Generate Antagonism Between Intratumoral Oncolytic Virus and Cyclophosphamide. Mol ther, Vol.19 (1), pp. 140-149.  show abstract

Hidalgo-Carcedo, C., Hooper, S., Chaudhry, S.I., Williamson, P., Harrington, K., Leitinger, B. & Sahai, E. (2011). Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat cell biol, Vol.13 (1), pp. 49-U123.  show abstract

Lolkema, M.P., Arkenau, H.-., Harrington, K., Roxburgh, P., Morrison, R., Roulstone, V., Twigger, K., Coffey, M., Mettinger, K., Gill, G., et al. (2011). A phase I study of the combination of intravenous reovirus type 3 Dearing and gemcitabine in patients with advanced cancer. Clin cancer res, Vol.17 (3), pp. 581-588.  show abstract

Nutting, C.M., Morden, J.P., Harrington, K.J., Urbano, T.G., Bhide, S.A., Clark, C., Miles, E.A., Miah, A.B., Newbold, K., Tanay, M., et al. (2011). Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet oncol, Vol.12 (2), pp. 127-136.  show abstract

Dwivedi, R.C., St Rose, S., Roe, J.W., Chisholm, E., Elmiyeh, B., Nutting, C.M., Clarke, P.M., Kerawala, C.J., Rhys-Evans, P.H., Harrington, K.J., et al. (2011). First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer. Head neck, Vol.33 (3), pp. 341-348.  show abstract

Luangdilok, S., Box, C., Harrington, K., Rhŷs-Evans, P. & Eccles, S. (2011). MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neck. Eur j cancer, Vol.47 (4), pp. 520-529.  show abstract

Sayed, S.I., Dwivedi, R.C., Katna, R., Garg, A., Pathak, K.A., Nutting, C.M., Rhys-Evans, P., Harrington, K.J. & Kazi, R. (2011). Implications of understanding cancer stem cell (CSC) biology in head and neck squamous cell cancer. Oral oncol, Vol.47 (4), pp. 237-243.  show abstract

Whitcher, B., Schmid, V.J., Collins, D.J., Orton, M.R., Koh, D.M., de Corcuera, I.D., Parera, M., del Campo, J.M., deSouza, N.M., Leach, M.O., et al. (2011). A Bayesian hierarchical model for DCE-MRI to evaluate treatment response in a phase II study in advanced squamous cell carcinoma of the head and neck. Magn reson mater phy, Vol.24 (2), pp. 85-96.  show abstract

Touchefeu, Y., Vassaux, G. & Harrington, K.J. (2011). Oncolytic viruses in radiation oncology. Radiother oncol, Vol.99 (3), pp. 262-270.  show abstract

Heinemann, L., Simpson, G.R., Boxall, A., Kottke, T., Relph, K.L., Vile, R., Melcher, A., Prestwich, R., Harrington, K.J., Morgan, R., et al. (2011). Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. Bmc cancer, Vol.11,  show abstract

Kottke, T., Errington, F., Pulido, J., Galivo, F., Thompson, J., Wongthida, P., Diaz, R.M., Chong, H., Ilett, E., Chester, J., et al. (2011). Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors. Nat med, Vol.17 (7), pp. 854-U223.  show abstract

Ahmed, M., Barbachano, Y., Riddell, A., Hickey, J., Newbold, K.L., Viros, A., Harrington, K.J., Marais, R. & Nutting, C.M. (2011). Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population. Eur j endocrinol, Vol.165 (2), pp. 315-322.  show abstract

Dwivedi, R.C., Dwivedi, R.C., Kazi, R., Kanwar, N., Nutting, C.M., Harrington, K.J. & Rhys-Evans, P.H. (2011). Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?. Anz j surg, Vol.81 (9), pp. 581-583.

Harrington, K. (2011). Virotherapy in the UK. Hum gene ther, Vol.22 (10), pp. A12-A12.

Kottke, T., Chester, J., Ilett, E., Thompson, J., Diaz, R., Coffey, M., Selby, P., Nuovo, G., Pulido, J., Mukhopadhyay, D., et al. (2011). Precise Scheduling of Chemotherapy Primes VEGF-producing Tumors for Successful Systemic Oncolytic Virotherapy. Mol ther, Vol.19 (10), pp. 1802-1812.  show abstract

Richard-Fiardo, P., Franken, P.R., Harrington, K.J., Vassaux, G. & Cambien, B. (2011). The use of molecular imaging of gene expression by radiotracers in gene therapy. Expert opin biol th, Vol.11 (10), pp. 1273-1285.  show abstract

Bourke, M.G., Salwa, S., Harrington, K.J., Kucharczyk, M.J., Forde, P.F., de Kruijf, M., Soden, D., Tangney, M., Collins, J.K. & O'Sullivan, G.C., et al. (2011). The emerging role of viruses in the treatment of solid tumours. Cancer treatment reviews, Vol.37 (8), pp. 618-632.

Morgan, R., Michael, A., Bhatt, A., Harrington, K., Boxall, A., Annels, N. & Pandha, H. (2011). HOX transcription factors promote cell survival in breast cancer. Cancer research, Vol.71.

Sourisseau, T., Harrington, K.J., Muller, W.J., Marshall, C.J. & White, D.E. (2011). Changes in tumor tissue organization in collagen-I sensitize cells to ionizing radiation in an ex vivo model of solid mammary tumor growth and local invasion. Cell cycle, Vol.10 (22), pp. 3979-3981.

Steven, N.M., Harrington, K.J., Lee, L., Jia, H., Tanday, M.K., Roberts, C., Edwards, C., McGuigan, L., Hartley, A.G., Viskaduraki, M., et al. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. J clin oncol, Vol.29 (15_suppl), p. e13028.  show abstract

Pedersen, J.V., Karapanagiotou, E.M., Biondo, A., Tunariu, N., Puglisi, M., Denholm, K.A., Sassi, S., Mansfield, D., Yap, T.A., De Bono, J.S., et al. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. J clin oncol, Vol.29 (15_suppl), p. 2577.  show abstract

Steven, N.M., Harrington, K.J., Lee, L., Jia, H., Tanday, M.K., Roberts, C., Edwards, C., McGuigan, L., Hartley, A.G., Viskaduraki, M., et al. (2011). A UK-based phase I trial of recombinant modified vaccinia ankara (MVA) vaccine encoding Epstein-Barr virus (EBV) antigens. Journal of clinical oncology, Vol.29 (15).

Pedersen, J.V., Karapanagiotou, E.M., Biondo, A., Tunariu, N., Puglisi, M., Denholm, K.A., Sassi, S., Mansfield, D., Yap, T.A., De Bono, J.S., et al. (2011). A phase I clinical trial of a genetically modified and imageable oncolytic vaccinia virus GL-ONC1 with clinical green fluorescent protein (GFP) imaging. Journal of clinical oncology, Vol.29 (15).

Steele, L., Errington, F., Prestwich, R., Ilett, E., Harrington, K., Pandha, H., Coffey, M., Selby, P., Vile, R. & Melcher, A., et al. (2011). Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-kappa B mediated and supports innate and adaptive anti-tumour immune priming. Mol cancer, Vol.10,  show abstract

del Campo, J.M., Hitt, R., Sebastian, P., Carracedo, C., Lokanatha, D., Bourhis, J., Temam, S., Cupissol, D., De Raucourt, D., Maroudias, N., et al. (2011). Effects of lapatinib monotherapy: results of a randomised phase II study in therapy-naive patients with locally advanced squamous cell carcinoma of the head and neck. Brit j cancer, Vol.105 (5), pp. 618-627.  show abstract

Harrington, K.J., Billingham, L.J., Brunner, T.B., Burnet, N.G., Chan, C.S., Hoskin, P., Mackay, R.I., Maughan, T.S., Macdougall, J., McKenna, W.G., et al. (2011). Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. Br j cancer, Vol.105 (5), pp. 628-639.

Charpidou, A., Gkiozos, I., Konstantinou, M., Eleftheraki, A., Demertzis, P., Harrington, K., Polyzos, A. & Syrigos, K.N. (2011). Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients. Cancer lett, Vol.304 (2), pp. 144-153.  show abstract

Syrigos, K.N., Karapanagiotou, E., Boura, P., Manegold, C. & Harrington, K. (2011). Bevacizumab-Induced Hypertension Pathogenesis and Management. Biodrugs, Vol.25 (3), pp. 159-169.  show abstract

Sayed, S.I., Manikantan, K., Khode, S., Jagade, M., Kasbekar, V.G., Shah, R., Palav, R.S., Nutting, C.M., Harrington, K.J., Rhys-Evans, P., et al. (2010). Tracheo-oesophageal Party Wall Thickness in Laryngectomised Patients in India: Implications for Surgical Voice Restoration. J surg oncol, Vol.101 (1), pp. 78-83.  show abstract

Harrington, K.J. (2010). Rash conclusions from a phase 3 study of cetuximab?. Lancet oncol, Vol.11 (1), pp. 2-3.

Bhide, S.A., Davies, M., Burke, K., McNair, H.A., Hansen, V., Barbachano, Y., El-Hariry, I.A., Newbold, K., Harrington, K.J. & Nutting, C.M., et al. (2010). WEEKLY VOLUME AND DOSIMETRIC CHANGES DURING CHEMORADIOTHERAPY WITH INTENSITY-MODULATED RADIATION THERAPY FOR HEAD AND NECK CANCER: A PROSPECTIVE OBSERVATIONAL STUDY. Int j radiat oncol, Vol.76 (5), pp. 1360-1368.  show abstract

Harrington, K.J., Hingorani, M., Tanay, M.A., Hickey, J., Bhide, S.A., Clarke, P.M., Renouf, L.C., Thway, K., Sibtain, A., McNeish, I.A., et al. (2010). Phase I/II Study of Oncolytic HSVGM-CSF in Combination with Radiotherapy and Cisplatin in Untreated Stage III/IV Squamous Cell Cancer of the Head and Neck. Clin cancer res, Vol.16 (15), pp. 4005-4015.  show abstract

Harrington, K.J., Karapanagiotou, E.M., Roulstone, V., Twigger, K.R., White, C.L., Vidal, L., Beirne, D., Prestwich, R., Newbold, K., Ahmed, M., et al. (2010). Two-stage phase I dose-escalation study of intratumoral reovirus type 3 dearing and palliative radiotherapy in patients with advanced cancers. Clin cancer res, Vol.16 (11), pp. 3067-3077.  show abstract

Ahmed, M., Schmidt, M., Sohaib, A., Kong, C., Burke, K., Richardson, C., Usher, M., Brennan, S., Riddell, A., Davies, M., et al. (2010). The value of magnetic resonance imaging in target volume delineation of base of tongue tumours - A study using flexible surface coils. Radiother oncol, Vol.94 (2), pp. 161-167.  show abstract

Bhide, S.A., Newbold, K.L., Harrington, K.J. & Nutting, C.M. (2010). Combined chemotherapy and intensity-modulated radiotherapy for the treatment of head and neck cancers. Expert rev anticanc, Vol.10 (3), pp. 297-300.

Hingorani, M., Spitzweg, C., Vassaux, G., Newbold, K., Melcher, A., Pandha, H., Vile, R. & Harrington, K. (2010). The Biology of the Sodium Iodide Symporter and its Potential for Targeted Gene Delivery. Curr cancer drug tar, Vol.10 (2), pp. 242-267.  show abstract

Dwivedi, R.C., St Rose, S., Roe, J.W., Khan, A.S., Pepper, C., Nutting, C.M., Clarke, P.M., Kerawala, C.J., Rhys-Evans, P.H., Harrington, K.J., et al. (2010). Validation of the Sydney Swallow Questionnaire (SSQ) in a cohort of head and neck cancer patients. Oral oncol, Vol.46 (4), pp. e10-e14.  show abstract

Harrington, K.J., Vile, R.G., Melcher, A., Chester, J. & Pandha, H.S. (2010). Clinical trials with oncolytic reovirus: moving beyond phase I into combinations with standard therapeutics. Cytokine growth factor rev, Vol.21 (2-3), pp. 91-98.  show abstract

Dwivedi, R.C., Kazi, R., Agrawal, N., Chisholm, E., St Rose, S., Elmiyeh, B., Rennie, C., Pepper, C., Clarke, P.M., Kerawala, C.J., et al. (2010). Comprehensive review of small bowel metastasis from head and neck squamous cell carcinoma. Oral oncol, Vol.46 (5), pp. 330-335.  show abstract

Harrington, K.J. & Nutting, C.M. (2010). Bravo for PRAVO. Lancet oncol, Vol.11 (5), pp. 407-408.

Bhide, S.A., Kazi, R., Newbold, K., Harrington, K.J. & Nutting, C.M. (2010). The role of intensity-modulated radiotherapy in head and neck cancer. Indian j cancer, Vol.47 (3), pp. 267-273.  show abstract

Harrington, K.J., Kazi, R., Bhide, S.A., Newbold, K. & Nutting, C.M. (2010). Novel therapeutic approaches to squamous cell carcinoma of the head and neck using biologically targeted agents. Indian j cancer, Vol.47 (3), pp. 248-259.  show abstract

Khan, A., Smellie, J., Nutting, C., Harrington, K. & Newbold, K. (2010). Familial Nonmedullary Thyroid Cancer: A Review of the Genetics. Thyroid, Vol.20 (7), pp. 795-801.  show abstract

Dandekar, P., Partridge, M., Kazi, R., Nutting, C., Harrington, K. & Newbold, K. (2010). Challenges in integrating 18FDG PET-CT into radiotherapy planning of head and neck cancer. Indian j cancer, Vol.47 (3), pp. 260-266.  show abstract

Merron, A., Baril, P., Martin-Duque, P., de la Vieja, A., Tran, L., Briat, A., Harrington, K.J., McNeish, I.A. & Vassaux, G. (2010). Assessment of the Na/I symporter as a reporter gene to visualize oncolytic adenovirus propagation in peritoneal tumours. Eur j nucl med mol i, Vol.37 (7), pp. 1377-1385.  show abstract

Pencavel, T., Seth, R., Hayes, A., Melcher, A., Pandha, H., Vile, R. & Harrington, K.J. (2010). Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?. Gene ther, Vol.17 (8), pp. 949-960.  show abstract

Powell, C., Newbold, K., Harrington, K.J., Bhide, S.A. & Nutting, C.M. (2010). External beam radiotherapy for differentiated thyroid cancer. Clin oncol (r coll radiol), Vol.22 (6), pp. 456-463.  show abstract

Hingorani, M., White, C.L., Zaidi, S., Pandha, H.S., Melcher, A.A., Bhide, S.A., Nutting, C.M., Syrigos, K.N., Vile, R.G., Vassaux, G., et al. (2010). Therapeutic Effect of Sodium Iodide Symporter Gene Therapy Combined With External Beam Radiotherapy and Targeted Drugs That Inhibit DNA Repair. Mol ther, Vol.18 (9), pp. 1599-1605.  show abstract

Morgan, R., Plowright, L., Harrington, K.J., Michael, A. & Pandha, H.S. (2010). Targeting HOX and PBX transcription factors in ovarian cancer. Bmc cancer, Vol.10,  show abstract

Maughan, T.S., Illidge, T.M., Hoskin, P., McKenna, W.G., Brunner, T.B., Stratford, I.J., Harrington, K.J., Plummer, R., Billingham, L.J., Nutting, C., et al. (2010). Radiotherapy Research Priorities for the UK. Clin oncol-uk, Vol.22 (8), pp. 707-709.

Roe, J.W., Carding, P.N., Dwivedi, R.C., Kazi, R.A., Rhys-Evans, P.H., Harrington, K.J. & Nutting, C.M. (2010). Swallowing outcomes following Intensity Modulated Radiation Therapy (IMRT) for head & neck cancer - a systematic review. Oral oncol, Vol.46 (10), pp. 727-733.  show abstract

Bhide, S.A., Gulliford, S., Fowler, J., Rosenfelder, N., Newbold, K., Harrington, K.J. & Nutting, C.M. (2010). Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy. Radiother oncol, Vol.97 (1), pp. 86-91.  show abstract

Kottke, T., Hall, G., Pulido, J., Diaz, R.M., Thompson, J., Chong, H., Selby, P., Coffey, M., Pandha, H., Chester, J., et al. (2010). Antiangiogenic cancer therapy combined with oncolytic virotherapy leads to regression of established tumors in mice. J clin invest, Vol.120 (5), pp. 1551-1560.  show abstract

Scott-Brown, M., Miah, A., Harrington, K. & Nutting, C. (2010). Evidence-based review: Quality of life following head and neck intensity-modulated radiotherapy. Radiother oncol, Vol.97 (2), pp. 249-257.  show abstract

Powell, C., Mikropoulos, C., Kaye, S.B., Nutting, C.M., Bhide, S.A., Newbold, K. & Harrington, K.J. (2010). Pre-clinical and clinical evaluation of PARP inhibitors as tumour-specific radiosensitisers. Cancer treat rev, Vol.36 (7), pp. 566-575.  show abstract

Ismail, M., Morgan, R., Harrington, K., Davies, J. & Pandha, H. (2010). Immunoregulatory effects of freeze injured whole tumour cells on human dendritic cells using an in vitro cryotherapy model. Cryobiology, Vol.61 (3), pp. 268-274.  show abstract

Heinemann, L., Simpson, G.R., Annels, N.E., Vile, R., Melcher, A., Prestwich, R., Harrington, K.J. & Pandha, H.S. (2010). The Effect of Cell Cycle Synchronization on Tumor Sensitivity to Reovirus Oncolysis. Mol ther, Vol.18 (12), pp. 2085-2093.  show abstract

Harrington, K.J. (2010). Topical treatment for oral cancers Winners and losers and oncolytic adenoviruses: who should be down in the mouth?. Gene ther, Vol.17 (12), pp. 1421-1422.

Touchefeu, Y., Harrington, K.J., Galmiche, J.P. & Vassaux, G. (2010). Review article: gene therapy, recent developments and future prospects in gastrointestinal oncology. Aliment pharm ther, Vol.32 (8), pp. 953-968.  show abstract

Comins, C., Spicer, J., Protheroe, A., Roulstone, V., Twigger, K., White, C.M., Vile, R., Melcher, A., Coffey, M.C., Mettinger, K.L., et al. (2010). REO-10: A Phase I Study of Intravenous Reovirus and Docetaxel in Patients with Advanced Cancer. Clin cancer res, Vol.16 (22), pp. 5564-5572.  show abstract

Kazi, R., Dwivedi, R.C., St Rose, S., Roe, J.W., Nutting, C., Rhys-Evans, P.H. & Harrington, K.J. (2010). Validation of first speech-specific questionnaire for English-speaking head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Harrington, K.J., Berrier, A., Robinson, M., Remenar, E., Housset, M., de Mendoza, F.H., Compton, N., Lau, M., Legenne, P. & Kumar, R., et al. (2010). Phase II study of oral lapatinib, a dual-tyrosine kinase inhibitor, combined with chemoradiotherapy (CRT) in patients (pts) with locally advanced, unresected squamous cell carcinoma of the head and neck (SCCHN). Journal of clinical oncology, Vol.28 (15).

Dwivedi, R.C., St Rose, S., Nutting, C., Rhys-Evans, P.H., Harrington, K.J. & Kazi, R. (2010). A report on the development and validation of first-ever perceptual speech evaluation tool for head and neck cancer (HNC) patients. Journal of clinical oncology, Vol.28 (15).

Karapanagiotou, E.M., Chester, J.D., Pandha, H.S., Gill, G.M., Coffey, M.C., Mettinger, K. & Harrington, K.J. (2010). A phase I/II study of oncolytic reovirus plus carboplatin/paclitaxel in patients with advanced solid cancers with emphasis on squamous cell carcinoma of the head and neck(SCCHN). Journal of clinical oncology, Vol.28 (15).

Senzer, N.N., Kaufman, H.L., Amatruda, T., Nemunaitis, M., Reid, T., Daniels, G., Gonzalez, R., Glaspy, J., Whitman, E., Harrington, K., et al. (2009). Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor-Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma. J clin oncol, Vol.27 (34), pp. 5763-5771.  show abstract

Hoskin, P.J., Robinson, M., Slevin, N., Morgan, D., Harrington, K. & Gaffney, C. (2009). Effect of Epoetin Alfa on Survival and Cancer Treatment-Related Anemia and Fatigue in Patients Receiving Radical Radiotherapy With Curative Intent for Head and Neck Cancer. J clin oncol, Vol.27 (34), pp. 5751-5756.  show abstract

Dandekar, P., Harmer, C., Barbachano, Y., Rhys-Evans, P., Harrington, K., Nutting, C. & Newbold, K. (2009). Hyperfractionated Accelerated Radiotherapy (HART) for anaplastic thyroid carcinoma: toxicity and survival analysis. Int j radiat oncol biol phys, Vol.74 (2), pp. 518-521.  show abstract

Agrawal, V.K., Copeland, K.M., Barbachano, Y., Rahim, A., Seth, R., White, C.L., Hingorani, M., Nutting, C.M., Kelly, M., Harris, P., et al. (2009). Microvascular free tissue transfer for gene delivery: in vivo evaluation of different routes of plasmid and adenoviral delivery. Gene ther, Vol.16 (1), pp. 78-92.  show abstract

Bhide, S.A., Ahmed, M., Rengarajan, V., Powell, C., Miah, A., Newbold, K., Nutting, C.M. & Harrington, K.J. (2009). ANEMIA DURING SEQUENTIAL INDUCTION CHEMOTHERAPY AND CHEMORADIATION FOR HEAD AND NECK CANCER: THE IMPACT OF BLOOD TRANSFUSION ON TREATMENT OUTCOME. Int j radiat oncol, Vol.73 (2), pp. 391-398.  show abstract

Harrington, K.J., El-Hariry, I.A., Holford, C.S., Lusinchi, A., Nutting, C.M., Rosine, D., Tanay, M., Deutsch, E., Matthews, J., D'Ambrosio, C., et al. (2009). Phase I Study of Lapatinib in Combination With Chemoradiation in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck. Journal of clinical oncology, Vol.27 (7), pp. 1100-1107.  show abstract

Prestwich, R.J., Ilett, E.J., Errington, F., Diaz, R.M., Steele, L.P., Kottke, T., Thompson, J., Galivo, F., Harrington, K.J., Pandha, H.S., et al. (2009). Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication. Clin cancer res, Vol.15 (13), pp. 4374-4381.  show abstract

Pandha, H.S., Heinemann, L., Simpson, G.R., Melcher, A., Prestwich, R., Errington, F., Coffey, M., Harrington, K.J. & Morgan, R. (2009). Synergistic Effects of Oncolytic Reovirus and Cisplatin Chemotherapy in Murine Malignant Melanoma. Clin cancer res, Vol.15 (19), pp. 6158-6166.  show abstract

Prestwich, R.J., Errington, F., Steele, L.P., Ilett, E.J., Morgan, R.S., Harrington, K.J., Pandha, H.S., Selby, P.J., Vile, R.G. & Melcher, A.A., et al. (2009). Reciprocal Human Dendritic Cell-Natural Killer Cell Interactions Induce Antitumor Activity Following Tumor Cell Infection by Oncolytic Reovirus. J immunol, Vol.183 (7), pp. 4312-4321.  show abstract

Peerlinck, I., Merron, A., Baril, P., Conchon, S., Martin-Duque, P., Hindorf, C., Burnet, J., Quintanilla, M., Hingorani, M., Iggo, R., et al. (2009). Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter. Clin cancer res, Vol.15 (21), pp. 6595-6601.  show abstract

Kottke, T., Pulido, J., Thompson, J., Sanchez-Perez, L., Chong, H., Calderwood, S.K., Selby, P., Harrington, K., Strome, S.E., Melcher, A., et al. (2009). Antitumor Immunity Can Be Uncoupled from Autoimmunity following Heat Shock Protein 70-Mediated Inflammatory Killing of Normal Pancreas. Cancer res, Vol.69 (19), pp. 7767-7774.  show abstract

Newbold, K., Castellano, I., Charles-Edwards, E., Mears, D., Sohaib, A., Leach, M., Rhys-Evans, P., Clarke, P., Fisher, C., Harrington, K., et al. (2009). AN EXPLORATORY STUDY INTO THE ROLE OF DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING OR PERFUSION COMPUTED TOMOGRAPHY FOR DETECTION OF INTRATUMORAL HYPOXIA IN HEAD-AND-NECK CANCER. Int j radiat oncol, Vol.74 (1), pp. 29-37.  show abstract

Kazi, R., Kanagalingam, J., Venkitaraman, R., Prasad, V., Clarke, P., Nutting, C.M., Rhys-Evans, P. & Harrington, K.J. (2009). Electroglottographic and perceptual evaluation of tracheoesophageal speech. J voice, Vol.23 (2), pp. 247-254.  show abstract

Plowright, L., Harrington, K.J., Pandha, H.S. & Morgan, R. (2009). HOX transcription factors are potential therapeutic targets in non-small-cell lung cancer (targeting HOX genes in lung cancer). Brit j cancer, Vol.100 (3), pp. 470-475.  show abstract

Kazi, R.A., Singh, A., Venkitaraman, R., Sayed, S.I., Rhys-Evans, P. & Harrington, K.J. (2009). Is electroglottography-based videostroboscopic assessment of post-laryngectomy prosthetic speech useful. J canc res ther, Vol.5 (2), pp. 85-92.  show abstract

Kazi, R., Rhys-Evans, P., Nutting, C.M. & Harrington, K.J. (2009). The great debate: stroboscopy vs high- speed imaging for assessment of alaryngeal phonation. J cancer res ther, Vol.5 (2), pp. 121-123.  show abstract

Pandha, H., D'Ambrosio, C., Heenan, S., Hyde, N., Di Palma, S., Nutting, C., Relph, K. & Harrington, K. (2009). Indium-labelled Autologous Dendritic Cells Migrate to Local Lymph Nodes after Intratumoural Injection in Head and Neck Cancer Patients. Clin oncol-uk, Vol.21 (4), pp. 363-364.

Syrigos, K.N., Karachalios, D., Karapanagiotou, E.M., Nutting, C.M., Manolopoulos, L. & Harrington, K.J. (2009). Head and neck cancer in the elderly: An overview on the treatment modalities. Cancer treat rev, Vol.35 (3), pp. 237-245.  show abstract

Terpos, E., Kiagia, M., Karapanagiotou, E.M., Charpidou, A., Dilana, K.D., Nasothimiou, E., Harrington, K.J., Polyzos, A. & Syrigos, K.N. (2009). The Clinical Significance of Serum Markers of Bone Turnover in NSCLC Patients: Surveillance, Management and Prognostic Implications. Anticancer res, Vol.29 (5), pp. 1651-1657.  show abstract

Ross, P.J., Teoh, E.M., A'hern, R.P., Rhys-Evans, P.H., Harrington, K.J., Nutting, C.M. & Gore, M.E. (2009). Epirubicin, cisplatin and protracted venous infusion 5-Fluorouracil chemotherapy for advanced salivary adenoid cystic carcinoma. Clin oncol (r coll radiol), Vol.21 (4), pp. 311-314.  show abstract

Ilett, E.J., Prestwich, R.J., Kottke, T., Errington, F., Thompson, J.M., Harrington, K.J., Pandha, H.S., Coffey, M., Selby, P.J., Vile, R.G., et al. (2009). Dendritic cells and T cells deliver oncolytic reovirus for tumour killing despite pre-existing anti-viral immunity. Gene ther, Vol.16 (5), pp. 689-699.  show abstract

Rogers, S.J., Box, C., Chambers, P., Barbachano, Y., Nutting, C.M., Rhŷs-Evans, P., Workman, P., Harrington, K.J. & Eccles, S.A. (2009). Determinants of response to epidermal growth factor receptor tyrosine kinase inhibition in squamous cell carcinoma of the head and neck. J pathol, Vol.218 (1), pp. 122-130.  show abstract

Pandha, H., Melcher, A., Harrington, K. & Vile, R. (2009). Oncolytic Viruses: Time to Compare, Contrast, and Combine?. Mol ther, Vol.17 (6), pp. 934-935.

Bhide, S.A., Miah, A., Barbachano, Y., Harrington, K.J., Newbold, K. & Nutting, C.M. (2009). Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005. Br j oral maxillofac surg, Vol.47 (4), pp. 284-289.  show abstract

Zaidi, S.H., Huddart, R.A. & Harrington, K.J. (2009). Novel targeted radiosensitisers in cancer treatment. Curr drug discov technol, Vol.6 (2), pp. 103-134.  show abstract

Pandha, H., Melcher, A., Harrington, K. & Vile, R. (2009). Oncolytic Viruses: Time to Compare, Contrast, and Combine?. Mol ther, Vol.17 (6), pp. 934-935.

Ismail, M., Bokaee, S., Morgan, R., Davies, J., Harrington, K.J. & Pandha, H. (2009). Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy (vol 100, pg 1889, 2009). Brit j cancer, Vol.101 (3), pp. 549-549.

Kazi, R., Nutting, C.M., Rhys-Evans, P. & Harrington, K.J. (2009). Significance and prognostic impact of comorbidity in head and neck cancer. J canc res ther, Vol.5 (3), pp. 145-147.

Dwivedi, R.C., Nutting, C.M., Rhys-Evans, P., Harrington, K.J. & Kazi, R. (2009). Future perspectives for health related quality of life (HRQOL) studies in head and neck cancer. G ital med lav ergon, Vol.31 (3 Suppl B), pp. B17-B20.  show abstract

Clark, C.H., Miles, E.A., Urbano, M.T., Bhide, S.A., Bidmead, A.M., Harrington, K.J., Nutting, C.M. & UK PARSPORT Trial Management Group collaborators, (2009). Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer. Br j radiol, Vol.82 (979), pp. 585-594.  show abstract

Nutting, C.M., van Herpen, C.M., Miah, A.B., Bhide, S.A., Machiels, J.P., Buter, J., Kelly, C., de Raucourt, D. & Harrington, K.J. (2009). Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma. Ann oncol, Vol.20 (7), pp. 1275-1279.  show abstract

Sayed, S.I., Elmiyeh, B., Rhys-Evans, P., Syrigos, K.N., Nutting, C.M., Harrington, K.J. & Kazi, R. (2009). Quality of life and outcomes research in head and neck cancer: A review of the state of the discipline and likely future directions. Cancer treat rev, Vol.35 (5), pp. 397-402.  show abstract

Kazi, R., Nutting, C.M., Rhys-Evans, P. & Harrington, K.J. (2009). A short perspective on the surgical restoration of alaryngeal speech. South med j, Vol.102 (8), pp. 838-840.  show abstract

Dwivedi, R.C., Kazi, R.A., Agrawal, N., Nutting, C.M., Clarke, P.M., Kerawala, C.J., Rhys-Evans, P.H. & Harrington, K.J. (2009). Evaluation of speech outcomes following treatment of oral and oropharyngeal cancers. Cancer treat rev, Vol.35 (5), pp. 417-424.  show abstract

Ismail, M., Bokaee, S., Davies, J., Harrington, K.J. & Pandha, H. (2009). Inhibition of the aquaporin 3 water channel increases the sensitivity of prostate cancer cells to cryotherapy. Brit j cancer, Vol.100 (12), pp. 1889-1895.  show abstract

Nutting, C.M., Miah, A.B., Bhide, S., Urbano, M.T., Barbachano, Y., Newbold, K.L. & Harrington, K.J. (2009). Dose-escalation Chemo-IMRT Improves Locoregional Control Rates in Organ Preservation Treatment of Locally Advanced Laryngeal and Hypopharyngeal Cancers. Clin oncol-uk, Vol.21 (8), pp. 646-647.

Ismail, M., Morgan, R., Harrington, K., Davies, J. & Pandha, H. (2009). Enhancing prostate cancer cryotherapy using tumour necrosis factor related apoptosis-inducing ligand (TRAIL) sensitisation in an in vitro cryotherapy model. Cryobiology, Vol.59 (2), pp. 207-213.  show abstract

Prestwich, R.J., Errington, F., Diaz, R.M., Pandha, H.S., Harrington, K.J., Melcher, A.A. & Vile, R.G. (2009). The Case of Oncolytic Viruses Versus the Immune System: Waiting on the Judgment of Solomon. Hum gene ther, Vol.20 (10), pp. 1119-1132.  show abstract

Willmon, C., Harrington, K., Kottke, T., Prestwich, R., Melcher, A. & Vile, R. (2009). Cell Carriers for Oncolytic Viruses: Fed Ex for Cancer Therapy. Mol ther, Vol.17 (10), pp. 1667-1676.  show abstract

Manikantan, K., Sayed, S.I., Syrigos, K.N., Rhys-Evans, P., Nutting, C.M., Harrington, K.J. & Kazi, R. (2009). Challenges for the future modifications of the TNM staging system for head and neck cancer: Case for a new computational model?. Cancer treat rev, Vol.35 (7), pp. 639-644.  show abstract

Manikantan, K., Khode, S., Dwivedi, R.C., Palav, R., Nutting, C.M., Rhys-Evans, P., Harrington, K.J. & Kazi, R. (2009). Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer treat rev, Vol.35 (8), pp. 744-753.  show abstract

Manikantan, K., Khode, S., Sayed, S.I., Roe, J., Nutting, C.M., Rhys-Evans, P., Harrington, K.J. & Kazi, R. (2009). Dysphagia in head and neck cancer. Cancer treat rev, Vol.35 (8), pp. 724-732.  show abstract

Bhide, S.A., Miah, A.B., Harrington, K.J., Newbold, K.L. & Nutting, C.M. (2009). Radiation-induced xerostomia: pathophysiology, prevention and treatment. Clin oncol (r coll radiol), Vol.21 (10), pp. 737-744.  show abstract

Kottke, T., Thompson, J., Diaz, R.M., Pulido, J., Willmon, C., Coffey, M., Selby, P., Melcher, A., Harrington, K. & Vile, R.G., et al. (2009). Improved Systemic Delivery of Oncolytic Reovirus to Established Tumors Using Preconditioning with Cyclophosphamide-Mediated Treg Modulation and Interleukin-2. Clin cancer res, Vol.15 (2), pp. 561-569.  show abstract

Nutting, C., A'Hern, R., Rogers, M.S., Sydenham, M.A., Adab, F., Harrington, K., Jefferies, S., Scrase, C., Yap, B.K., Hall, E., et al. (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537). J clin oncol, Vol.27 (15_suppl), p. LBA6006.  show abstract

Harrington, K., Hingorani, M., Tanay, M., Matthews, J., Newbold, K., Renouf, L., Coffin, R.S., McNeish, I. & Nutting, C. (2009). Phase I/II dose escalation study of OncoVex(GM-CSF) and chemoradiotherapy (CRT) in untreated stage III/IV squamous cell cancer of the head and neck (SCCHN). J clin oncol, Vol.27 (15_suppl), p. 6018.  show abstract

Karapanagiotou, E., Pandha, H.S., Hall, G., Chester, J., Melcher, A., Coffey, M., de Bono, J., Gore, M.E., Nutting, C.M. & Harrington, K.J., et al. (2009). Phase I/II trial of oncolytic reovirus (Reolysin) in combination with carboplatin/paclitaxel in patients (pts) with advanced solid cancers. J clin oncol, Vol.27 (15_suppl), p. e14519.  show abstract

Bhide, S., Gulliford, S., A'Hern, R., Hall, E., Newbold, K., Harrington, K. & Nutting, C. (2009). Quantitative estimates of the effects of concomitant chemotherapy on acute dysphagia in patients receiving radical treatment for head and neck cancer. J clin oncol, Vol.27 (15_suppl), p. e22134.  show abstract

Rudman, S.M., Comins, C., Mukherji, D., Coffey, M., Mettinger, K., Protheroe, A., Harrington, K.J., Pandha, H. & Spicer, J.F. (2009). Results of a phase I study to evaluate the feasibility, safety, and biological effects of intravenous administration of wild-type reovirus with docetaxel to patients with advanced malignancies. J clin oncol, Vol.27 (15_suppl), p. e13524.  show abstract

Saunders, M., Anthoney, A., Coffey, M., Mettinger, K., Thompson, B., Melcher, A., Nutting, C.M. & Harrington, K. (2009). Results of a phase II study to evaluate the biological effects of intratumoral (ITu) reolysin in combination with low dose radiotherapy (RT) in patients (Pts) with advanced cancers. J clin oncol, Vol.27 (15_suppl), p. e14514.  show abstract

Nutting, C., A'Hern, R., Rogers, M.S., Sydenham, M.A., Adab, F., Harrington, K., Jefferies, S., Scrase, C., Yap, B.K., Hall, E., et al. (2009). First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005). J clin oncol, Vol.27 (18_suppl), p. LBA6006.  show abstract

Ahmed, M., Hansen, V.N., Harrington, K.J. & Nutting, C.M. (2009). Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med dosim, Vol.34 (3), pp. 217-224.  show abstract

McGough, C., Wedlake, L., Baldwin, C., Hackett, C., Norman, A.R., Blake, P., Harrington, K., Tait, D., Khoo, V., Frost, G., et al. (2008). Clinical trial: normal diet vs partial replacement with oral E028 formula for the prevention of gastrointestinal toxicity in cancer patients undergoing pelvic radiotherapy. Aliment pharmacol ther, Vol.27 (11), pp. 1132-1139.  show abstract

Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Rhys-Evans, P., Nutting, C.M. & Harrington, K.J. (2008). Electroglottographic comparison of voice outcomes in patients with advanced laryngopharyngeal cancer treated by chemoradiotherapy or total laryngectomy. Int j radiat oncol biol phys, Vol.70 (2), pp. 344-352.  show abstract

Errington, F., Steele, L., Prestwich, R., Harrington, K.J., Pandha, H.S., Vidal, L., de Bono, J., Selby, P., Coffey, M., Vile, R., et al. (2008). Reovirus activates human dendritic cells to promote innate antitumor immunity. J immunol, Vol.180 (9), pp. 6018-6026.  show abstract

Hingorani, M., White, C.L., Zaidi, S., Merron, A., Peerlinck, I., Gore, M.E., Nutting, C.M., Pandha, H.S., Melcher, A.A., Vile, R.G., et al. (2008). Radiation-mediated up-regulation of gene expression from replication-defective adenoviral vectors: Implications for sodium iodide symporter gene therapy. Clin cancer res, Vol.14 (15), pp. 4915-4924.  show abstract

Hingorani, M., White, C.L., Merron, A., Peerlinck, I., Gore, M.E., Slade, A., Scott, S.D., Nutting, C.M., Pandha, H.S., Melcher, A.A., et al. (2008). Inhibition of Repair of Radiation-Induced DNA Damage Enhances Gene Expression from Replication-Defective Adenoviral Vectors. Cancer res, Vol.68 (23), pp. 9771-9778.  show abstract

Vidal, L., Pandha, H.S., Yap, T.A., White, C.L., Twigger, K., Vile, R.G., Melcher, A., Coffey, M., Harrington, K.J. & DeBono, J.S., et al. (2008). A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin cancer res, Vol.14 (21), pp. 7127-7137.  show abstract

Twigger, K., Vidal, L., White, C.L., De Bono, J.S., Bhide, S., Coffey, M., Thompson, B., Vile, R.G., Heinemann, L., Pandha, H.S., et al. (2008). Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy. Clin cancer res, Vol.14 (3), pp. 912-923.  show abstract

Qiao, J., Wang, H.X., Kottke, T., White, C., Twigger, K., Diaz, R.M., Thompson, J., Selby, P., de Bono, J., Melcher, A., et al. (2008). Cyclophosphamide facilitates antitumor efficacy against subcutaneous tumors following intravenous delivery of reovirus. Clin cancer res, Vol.14 (1), pp. 259-269.  show abstract

Qiao, J., Kottke, T., Willmon, C., Galivo, F., Wongthida, P., Diaz, R.M., Thompson, J., Ryno, P., Barber, G.N., Chester, J., et al. (2008). Purging metastases in lymphoid organs using a combination of antigen-nonspecific adoptive T cell therapy, oncolytic virotherapy and immunotherapy. Nat med, Vol.14 (1), pp. 37-44.  show abstract

Lee, B., Cook, G., John, L., Harrington, K. & Nutting, C. (2008). Follicular thyroid carcinoma metastasis to the esophagus detected by 18FDG PET/CT. Thyroid, Vol.18 (2), pp. 267-271.  show abstract

Singh, A., Kazi, R., Venkitaraman, R., Kapoor, K., Nutting, C., Clarke, P., Rhys, E.P. & Harrington, K. (2008). Does flexible videostroboscopy compare with rigid videostroboscopy in the assessment of the neoglottis? A preliminary report. Clin otolaryngol, Vol.33 (1), pp. 60-63.  show abstract

White, C.L., Menghistu, T., Twigger, K.R., Searle, P.F., Bhide, S.A., Vile, R.G., Melcher, A.A., Pandha, H.S. & Harrington, K.J. (2008). Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo. Gene ther, Vol.15 (6), pp. 424-433.  show abstract

Wedlake, L., McGough, C., Hackett, C., Thomas, K., Blake, P., Harrington, K., Tait, D., Khoo, V., Dearnaley, D. & Andreyev, H.J., et al. (2008). Can biological markers act as non-invasive, sensitive indicators of radiation-induced effects in the gastrointestinal mucosa?. Aliment pharmacol ther, Vol.27 (10), pp. 980-987.  show abstract

Kazi, R., Venkitaraman, R., Johnson, C., Prasad, V., Clarke, P., Newbold, K., Rhys-Evans, P., Nutting, C. & Harrington, K. (2008). Prospective, longitudinal electroglottographic study of voice recovery following accelerated hypofractionated radiotherapy for T1/T2 larynx cancer. Radiother oncol, Vol.87 (2), pp. 230-236.  show abstract

Jankowska, P., Teoh, E.M., Fisher, C., Rhys Evans, P., Nutting, C.M. & Harrington, K.J. (2008). Case report Isolated intrathyroid metastasis from undifferentiated and squamous carcinoma of the head and neck: the case for surgery and re-irradiation. Br j radiol, Vol.81 (966), pp. e154-e161.  show abstract

Nutting, C.M., Bhide, S.A. & Harrington, K.J. (2008). Treatment of head and neck cancer. New engl j med, Vol.358 (10), pp. 1076-1077.

White, C.L., Twigger, K.R., Vidal, L., De Bono, J.S., Coffey, M., Heinemann, L., Morgan, R., Merrick, A., Errington, F., Vile, R.G., et al. (2008). Characterization of the adaptive and innate immune response to intravenous oncolytic reovirus (Dearing type 3) during a phase I clinical trial. Gene ther, Vol.15 (12), pp. 911-920.  show abstract

Kazi, R., Johnson, C., Prasad, V., De Cordova, J., Venkitaraman, R., Nutting, C.M., Clarke, P., Evans, P.R. & Harrington, K.J. (2008). Quality of life outcome measures following partial glossectomy: assessment using the UW-QOL scale. J cancer res ther, Vol.4 (3), pp. 116-120.  show abstract

Prestwich, R.J., Harrington, K.J., Vile, R.G. & Melcher, A.A. (2008). Immunotherapeutic potential of oncolytic virotherapy. Lancet oncol, Vol.9 (7), pp. 610-612.

Kottke, T., Galivo, F., Wongthida, P., Diaz, R.M., Thompson, J., Jevremovic, D., Barber, G.N., Hall, G., Chester, J., Selby, P., et al. (2008). Treg depletion-enhanced IL-2 treatment facilitates therapy of established tumors using systemically delivered oncolytic virus. Mol ther, Vol.16 (7), pp. 1217-1226.  show abstract

Syrigos, K.N., Katirtzoglou, N., Kotteas, E. & Harrington, K. (2008). Adhesion molecules in lung cancer: Implications in the pathogenesis and management. Curr pharm design, Vol.14 (22), pp. 2173-2183.  show abstract

Bhide, S.A., Ahmed, M., Barbachano, Y., Newbold, K., Harrington, K.J. & Nutting, C.M. (2008). Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. Brit j cancer, Vol.99 (1), pp. 57-62.  show abstract

Harrington, K.J., Melcher, A., Vassaux, G., Pandha, H.S. & Vile, R.G. (2008). Exploiting synergies between radiation and oncolytic viruses. Curr opin mol ther, Vol.10 (4), pp. 362-370.  show abstract

Errington, F., White, C.L., Twigger, K.R., Rose, A., Scott, K., Steele, L., Ilett, L.J., Prestwich, R., Pandha, H.S., Coffey, M., et al. (2008). Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene ther, Vol.15 (18), pp. 1257-1270.  show abstract

Comins, C., Heinemann, L., Harrington, K., Melcher, A., De Bono, J. & Pandha, H. (2008). Reovirus: Viral therapy for cancer 'as nature intended'. Clin oncol-uk, Vol.20 (7), pp. 548-554.  show abstract

Prestwich, R.J., Harrington, K.J., Pandha, H.S., Vile, R.G., Melcher, A.A. & Errington, F. (2008). Oncolytic viruses: a novel form of immunotherapy. Expert rev anticanc, Vol.8 (10), pp. 1581-1588.  show abstract

Shears, L., Plowright, L., Harrington, K., Pandha, H.S. & Morgan, R. (2008). Disrupting the Interaction Between HOX and PBX Causes Necrotic and Apoptotic Cell Death in the Renal Cancer Lines CaKi-2 and 769-P. J urology, Vol.180 (5), pp. 2196-2201.  show abstract

Yap, T.A., Brunetto, A., Pandha, H., Harrington, K. & de Bono, J.S. (2008). Reovirus therapy in cancer: has the orphan virus found a home?. Expert opin inv drug, Vol.17 (12), pp. 1925-1935.  show abstract

Kottke, T., Diaz, R.M., Kaluza, K., Pulido, J., Galivo, F., Wongthida, P., Thompson, J., Willmon, C., Barber, G.N., Chester, J., et al. (2008). Use of Biological Therapy to Enhance Both Virotherapy and Adoptive T-Cell Therapy for Cancer. Mol ther, Vol.16 (12), pp. 1910-1918.  show abstract

Prestwich, R.J., Errington, F., Ilett, E.J., Morgan, R.S., Scott, K.J., Kottke, T., Thompson, J., Morrison, E.E., Harrington, K.J., Pandha, H.S., et al. (2008). Tumor Infection by Oncolytic Reovirus Primes Adaptive Antitumor Immunity. Clin cancer res, Vol.14 (22), pp. 7358-7366.  show abstract

Ahmed, M., Barbachano, Y., Riddell, A.M., Whittaker, S., Newbold, K., Harrington, K., Marais, R. & Nutting, C.M. (2008). Preliminary results of an open labelled phase 2 study evaluating the safety and efficacy of sorafenib in metastatic advanced thyroid cancer. Journal of clinical oncology, Vol.26 (15).

Bhide, S.A., Ahmed, M., Powell, C., Newbold, K., Nutting, C.M. & Harrington, K. (2008). Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: The impact of blood transfusion on treatment outcome. Journal of clinical oncology, Vol.26 (15).

Prestwich, R.J., Errington, F., Harrington, K.J., Pandha, H.S., Selby, P. & Melcher, A. (2008). Oncolytic viruses: do they have a role in anti-cancer therapy?. Clin med oncol, Vol.2, pp. 83-96.  show abstract

Kazi, R., Prasad, V., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2008). Questionnaire analysis of swallowing-related outcomes following glossectomy. Orl j otorhinolaryngol relat spec, Vol.70 (3), pp. 151-155.  show abstract

Newbold, K.L., Partridge, M., Cook, G., Sharma, B., Rhys-Evans, P., Harrington, K.J. & Nutting, C.M. (2008). Evaluation of the role of (18)FDG-PET/CT in radiotherapy target definition in patients with head and neck cancer. Acta oncologica, Vol.47 (7), pp. 1229-1236.  show abstract

Kazi, R., Singh, A., Al-Mutairy, A., De Cordova, J., O'Leary, L., Nutting, C., Clarke, P., Evans, P.R. & Harrington, K. (2008). Electroglottographic analysis of valved speech following total laryngectomy. Logop phoniatr voco, Vol.33 (1), pp. 12-21.  show abstract

Rogers, S., Box, C., Nutting, C., Rhys Evans, P., Harrington, K. & Eccles, S. (2007). MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck. Current enzyme inhibition, Vol.3 (1), pp. 1-12.

Bhide, S.A., Harrington, K.J. & Nutting, C.M. (2007). Otological toxicity after postoperative radiotherapy for parotid tumours. Clin oncol (r coll radiol), Vol.19 (1), pp. 77-82.  show abstract

McGough, C., Wedlake, L., Hackett, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K. & Andreyev, H.J., et al. (2007). Use of simple biological markers to monitor gastrointestinal toxicity during pelvic radiotherapy. Clin oncol-uk, Vol.19 (3), pp. S39-S39.

Ho, G., Jankowska, P., Perrin, R., Banks, C., Teoh, E. & Harrington, K. (2007). Dosimetric problems of radiotherapy to synchronous bilateral acinic cell carcinoma of parotid glands. Clin oncol-uk, Vol.19 (3), pp. S31-S31.

McGough, C., Baidwint, C., Hackett, C., Wedlake, L., Norman, A., Frost, G., Blake, P., Tai, D., Khoo, V., Harrington, K., et al. (2007). A randomised controlled trial of elemental diet during pelvic radiotherapy. Clin oncol-uk, Vol.19 (3), pp. S11-S11.

Hingorani, M., White, C.L., Agrawal, V.K., Vidal, L., Melcher, A. & Harrington, K.J. (2007). Combining radiation and cancer gene therapy: a potential marriage of physical and biological targeting?. Curr cancer drug targets, Vol.7 (4), pp. 389-409.  show abstract

Kazi, R., Prasad, V.M., Kanagalingam, J., Georgalas, C., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2007). Analysis of formant frequencies in patients with oral or oropharyngeal cancers treated by glossectomy. Int j lang commun disord, Vol.42 (5), pp. 521-532.  show abstract

Macpherson, I.R., Hooper, S., Serrels, A., McGarry, L., Ozanne, B.W., Harrington, K., Frame, M.C., Sahai, E. & Brunton, V.G. (2007). p120-catenin is required for the collective invasion of squamous cell carcinoma cells via a phosphorylation-independent mechanism. Oncogene, Vol.26 (36), pp. 5214-5228.  show abstract

Guerrero Urbano, M.T., Clark, C.H., Kong, C., Miles, E., Dearnaley, D.P., Harrington, K.J., Nutting, C.M. & PARSPORT Trial Management Group, (2007). Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. Clin oncol (r coll radiol), Vol.19 (8), pp. 604-613.  show abstract

Jankowska, P.J., Kong, C., Burke, K., Harrington, K.J. & Nutting, C. (2007). A systematic study of posterior cervical lymph node irradiation with electrons: Conventional versus customized planning. Radiother oncol, Vol.85 (1), pp. 132-137.  show abstract

Urbano, T.G., Clark, C.H., Hansen, V.N., Adams, E.J., Miles, E.A., Mc Nair, H., Bidmead, A.M., Warrington, J., Dearnaley, D.P., Harmer, C., et al. (2007). Intensity Modulated Radiotherapy (IMRT) in locally advanced thyroid cancer: acute toxicity results of a phase I study. Radiother oncol, Vol.85 (1), pp. 58-63.  show abstract

Guerrero Urbano, T., Clark, C.H., Hansen, V.N., Adams, E.J., A'Hern, R., Miles, E.A., McNair, H., Bidmead, M., Warrington, A.P., Dearnaley, D.P., et al. (2007). A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer. Radiother oncol, Vol.85 (1), pp. 36-41.  show abstract

Harrington, K., Jankowska, P. & Hingorani, M. (2007). Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer. Clin oncol-uk, Vol.19 (8), pp. 561-571.  show abstract

Kazi, R.A., Prasad, V.M., Kanagalingam, J., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2007). Assessment of the formant frequencies in normal and laryngectomized individuals using linear predictive coding. J voice, Vol.21 (6), pp. 661-668.  show abstract

Kazi, R., De Cordova, J., Singh, A., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2007). Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales. J voice, Vol.21 (6), pp. 728-734.  show abstract

Merron, A., Peerlinck, I., Martin-Duque, P., Burnet, J., Quintanilla, M., Mather, S., Hingorani, M., Harrington, K., Iggo, R. & Vassaux, G., et al. (2007). SPECT/CT imaging of oncolytic adenovirus propagation in tumours in vivo using the Na/I symporter as a reporter gene. Gene therapy, Vol.14 (24), pp. 1731-1738.

Harris, D., Vidal, L., Melcher, A., Newbold, K., Anthony, A., Karavasilis, V., Agarwal, R., White, C., Twigger, K., Coffey, M., et al. (2007). A Phase I study to evaluate the feasibility, safety and biological effects of intratumoural administration of wild-type Reovirus (REOLYSIN (R)) in combination with radiation in patients with advanced malignancies. Mol cancer ther, Vol.6 (12), pp. 3458S-3458S.

Gaggioli, C., Hooper, S., Hidalgo-Carcedo, C., Grosse, R., Marshall, J.F., Harrington, K. & Sahai, E. (2007). Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat cell biol, Vol.9 (12), pp. 1392-U92.  show abstract

Kottke, T., Sanchez-Perez, L., Diaz, R.M., Thompson, J., Chong, H., Harrington, K., Calderwood, S.K., Pulido, J., Georgopoulos, N., Selby, P., et al. (2007). Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer res, Vol.67 (24), pp. 11970-11979.  show abstract

Luangdilok, S., Box, C., Patterson, L., Court, W., Harrington, K., Pitkin, L., Rhŷs-Evans, P., O-charoenrat, P. & Eccles, S. (2007). Syk tyrosine kinase is linked to cell motility and progression in squamous cell carcinomas of the head and neck. Cancer res, Vol.67 (16), pp. 7907-7916.  show abstract

Pitkin, L., Luangdilok, S., Corbishley, C., Wilson, P.O., Dalton, P., Bray, D., Mady, S., Williamson, P., Odutoye, T., Evans, P.R., et al. (2007). Expression of CC chemokine receptor 7 in tonsillar cancer predicts cervical nodal metastasis, systemic relapse and survival. Brit j cancer, Vol.97 (5), pp. 670-677.  show abstract

Bhide, S., Clark, C., Harrington, K. & Nutting, C.M. (2007). Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site. Med dosim, Vol.32 (3), pp. 188-195.  show abstract

Kazi, R., Singh, A., De Cordova, J., Al-Mutairy, A., O'Leary, L., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2007). Postlaryngectomy vocal rehabilitation: assessment using a validated questionnaire in 51 patients. Orl j otorhinolaryngol relat spec, Vol.69 (5), pp. 289-294.  show abstract

Kazi, R., De Cordova, J., Kanagalingam, J., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2007). Quality of life following total laryngectomy: assessment using the UW-QOL scale. Orl j otorhinolaryngol relat spec, Vol.69 (2), pp. 100-106.  show abstract

Khalid, U., McGough, C., Hackett, C., Blake, P., Harrington, K.J., Khoo, V.S., Tait, D., Norman, A.R. & Andreyev, H.J. (2006). A modified inflammatory bowel disease questionnaire and the Vaizey Incontinence questionnaire are more sensitive measures of acute gastrointestinal toxicity during pelvic radiotherapy than RTOG grading. Int j radiat oncol biol phys, Vol.64 (5), pp. 1432-1441.  show abstract

Errington, F., Jones, J., Merrick, A., Bateman, A., Harrington, K., Gough, M., O'Donnell, D., Selby, P., Vile, R. & Melcher, A., et al. (2006). Fusogenic membrane glycoprotein-mediated tumour cell fusion activates human dendritic cells for enhanced IL-12 production and T-cell priming. Gene ther, Vol.13 (2), pp. 138-149.  show abstract

Guerrero Urbano, M.T., Henrys, A.J., Adams, E.J., Norman, A.R., Bedford, J.L., Harrington, K.J., Nutting, C.M., Dearnaley, D.P. & Tait, D.M. (2006). Intensity-modulated radiotherapy in patients with locally advanced rectal cancer reduces volume of bowel treated to high dose levels. Int j radiat oncol biol phys, Vol.65 (3), pp. 907-916.  show abstract

Kazi, R., Kiverniti, E., De-Cordova, J., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2006). Quality of life assessment in laryngectomized individuals. Clin otolaryngol, Vol.31 (1), pp. 83-84.

Kazi, R., Kanagalingam, J., Al-Mutairy, A., Nutting, C.M., Clarke, P., Rhys-Evans, P.H. & Harrington, K.J. (2006). Predictors of speech and swallowing function following primary surgery for oral and oropharyngeal cancer. Clin otolaryngol, Vol.31 (1), pp. 83-83.

Vidal, L., Yap, T.A., White, C.L., Twigger, K., Hingorani, M., Agrawal, V., Kaye, S.B., Harrington, K.J. & de Bono, J.S. (2006). Reovirus and other oncolytic viruses for the targeted treatment of cancer. Target oncol, Vol.1 (3), pp. 130-150.  show abstract

Newbold, K., Partridge, M., Cook, G., Sohaib, S.A., Charles-Edwards, E., Rhys-Evans, P., Harrington, K. & Nutting, C. (2006). Advanced imaging applied to radiotherapy planning in head and neck cancer: a clinical review. Br j radiol, Vol.79 (943), pp. 554-561.  show abstract

Nutting, C., Horlock, N., A'Hern, R., Searle, A., Henk, J.M., Rhys-Evans, P. & Harrington, K. (2006). Manually after-loaded 192Ir low-dose rate brachytherapy after subtotal excision and flap reconstruction of recurrent cervical lymphadenopathy from head and neck cancer. Radiother oncol, Vol.80 (1), pp. 39-42.  show abstract

Kazi, R., Singh, A., De Cordova, J., Al-Mutairy, A., Clarke, P., Nutting, C., Rhys-Evans, P. & Harrington, K. (2006). Validation of a voice prosthesis questionnaire to assess valved speech and its related issues in patients following total laryngectomy. Clin otolaryngol, Vol.31 (5), pp. 404-410.  show abstract

Yap, T.A., Vidal, L., Pandha, H., Spicer, J., Digue, L., Coffey, M., Thompson, B., Kaye, S.B., Harrington, K.J. & De-Bono, J.S., et al. (2006). A phase I study of wild-type reovirus, which selectively replicates in cells expressing activated Ras, administered intravenously to patients with advanced cancer. Ejc suppl, Vol.4 (12), pp. 108-108.

Kazi, R., Prasad, V., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2006). Questionnaire analysis of the swallowing-related outcomes following total laryngectomy. Clin otolaryngol, Vol.31 (6), pp. 525-530.  show abstract

Kazi, R., Singh, A., Mullan, G.P., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2006). Can objective parameters derived from videofluoroscopic assessment of post-laryngectomy valved speech replace current subjective measures? An e-tool-based analysis. Clin otolaryngol, Vol.31 (6), pp. 518-524.  show abstract

Kazi, R., Kiverniti, E., Prasad, V., Venkitaraman, R., Nutting, C.M., Clarke, P., Rhys-Evans, P. & Harrington, K.J. (2006). Multidimensional assessment of female tracheoesophageal prosthetic speech. Clin otolaryngol, Vol.31 (6), pp. 511-517.  show abstract

McGough, C., Peacock, N., Hackett, C., Baldwin, C., Norman, A., Frost, G., Blake, P., Tait, D., Khoo, V., Harrington, K., et al. (2006). Taste preferences for oral nutrition supplements in patients before and after pelvic radiotherapy: a double-blind controlled study. Clin nutr, Vol.25 (6), pp. 906-912.  show abstract

Kirby, A.M., A'Hern, R.P., D'Ambrosio, C., Tanay, M., Syrigos, K.N., Rogers, S.J., Box, C., Eccles, S.A., Nutting, C.M. & Harrington, K.J., et al. (2006). Gefitinib (ZD1839, Iressa(TM)) as palliative treatment in recurrent or metastatic head and neck cancer. Brit j cancer, Vol.94 (5), pp. 631-636.  show abstract

Hu, J.C., Coffin, R.S., Davis, C.J., Graham, N.J., Groves, N., Guest, P.J., Harrington, K.J., James, N.D., Love, C.A., McNeish, I., et al. (2006). A phase I study of OncoVEXGM-CSF, a second-generation oncolytic herpes simplex virus expressing granulocyte macrophage colony-stimulating factor. Clin cancer res, Vol.12 (22), pp. 6737-6747.  show abstract

Errington, F., Bateman, A., Kottke, T., Thompson, J., Harrington, K., Merrick, A., Hatfield, P., Selby, P., Vile, R. & Melcher, A., et al. (2006). Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy. Clin cancer res, Vol.12 (4), pp. 1333-1341.  show abstract

Vidal, L., Pandha, H., Spicer, J., Harrington, K.J., Allen, S., Leader, D., Coffey, M., Thompson, B., Kaye, S. & De-Bono, J., et al. (2006). A phase I study of reolysin given intravenously to patients with advanced malignancies. J clin oncol, Vol.24 (18_suppl), p. 3064.  show abstract

Harrington, K.J., Bourhis, J., Nutting, C.M., Rosine, D., Theodosiou, A.M., Gardiner, S., Berger, M.S., Beelen, A.P., Stead, A.G. & El-Hariry, I.A., et al. (2006). A phase I, open-label study of lapatinib plus chemoradiation in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). J clin oncol, Vol.24 (18_suppl), p. 5553.  show abstract

Harrington, K.J., Nutting, C.M. & Pandha, H.S. (2005). Gene therapy for head and neck cancer. Cancer metastasis rev, Vol.24 (1), pp. 147-164.  show abstract

Rogers, S.J., Harrington, K.J., Rhys-Evans, P., O-Charoenrat, P. & Eccles, S.A. (2005). Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer metastasis rev, Vol.24 (1), pp. 47-69.  show abstract

Hatfield, P., Merrick, A., Harrington, K., Vile, R., Bateman, A., Selby, P. & Melcher, A. (2005). Radiation-induced cell death and dendritic cells: Potential for cancer immunotherapy?. Clin oncol-uk, Vol.17 (1), pp. 1-11.  show abstract

Mavria, G., Harrington, K.J., Marshall, C.J. & Porter, C.D. (2005). In vivo efficacy of HSV-TK transcriptionally targeted to the tumour vasculature is augmented by combination with cytotoxic chemotherapy. J gene med, Vol.7 (3), pp. 263-275.  show abstract